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A B S T R A C T  
The object of the present study is to assess today’s patent system as it encroaches with 
broader areas such as technical innovation, economics and policy making, which have 
contributed to its very existence as much as the patent system have influenced them. In the 
case of Information and Communication Technology (ICT)—characterized by complexity, 
highly cumulative innovation processes and quick obsolescence—patent rights, which 
protect exclusive commercial exploits, are defective, as the overlapping of different patent 
protections may force companies to share revenues and cause blockages on manufacture. 
Although aimed at spurring overall progress, the patent system may indeed have a 
detrimental effect on innovation, manufacture and competitiveness in the ICT market. A 
bifurcated patent system could better respond to the needs of technology and society. 
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R E S U M  
L’objectiu del present estudi és avaluar el sistema de patents, des d’un punt de vista 
multidisciplinari, analitzant la innovació tecnològica, el context econòmic i la regulació legal, 
àrees que han contribuït al desenvolupament de l’actual sistema de patents, tant com aquest 
ha influït en elles. En el cas de les Tecnologies de la Informació i les Comunicacions (TIC)—
caracteritzades per la seva complexitat, els processos de innovació altament acumulatius i la 
seva ràpida obsolescència—, els drets de patent, que protegeixen l’explotació comercial 
exclusiva, són imperfectes, donat que la superposició de les diferents proteccions conferides 
per les patents obliga a les companyies a distribuir-se els beneficis, permetent també 
possibles bloquejos de la producció tecnològica. Encara que estimular el progrés és l’objectiu 
del sistema de patents, aquest pot tenir un efecte perjudicial a la innovació, fabricació i 
competitivitat al mercat de les TIC. Un sistema de patents bifurcat podria respondre millor a 
les necessitats tecnològiques i socials. 
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R E S U M E N  
El objeto del presente estudio es evaluar el sistema de patentes, desde un punto de vista 
multidisciplinar, analizando la innovación tecnológica, el contexto económico y la regulación 
legal, áreas que han contribuido al desarrollo del actual sistema de patentes tanto como éste 
ha influido en aquéllas. En el caso de las Tecnologías de la Información y las Comunicaciones 
(TIC)—caracterizadas por su complejidad, los procesos de innovación altamente 
acumulativos y su rápida obsolescencia—, los derechos de patente, que protegen la 
explotación comercial exclusiva, son imperfectos, ya que la superposición de las diferentes 
protecciones conferidas por las patentes obliga a las compañías a racionar beneficios, 
pudiendo además causar bloqueos en la producción tecnológica. A pesar de que estimular el 
progreso es el objetivo del sistema de patentes, éste puede tener un efecto perjudicial en la 
innovación, fabricación y competitividad en el mercado de las TIC. Un sistema de patentes 
bifurcado podría responder mejor a las necesidades tecnológicas y sociales. 
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F O R E W O R D  
The purpose of the present study is to develop an objective assessment of the patent system. 
During its preliminary research and later development it became obvious that patent system 
literature consisted primarily of more or less biased sources: patent offices, governmental 
agencies, economic reviews, legal academics and representatives of certain industries. A 
considerable effort has been made to acquire an objective view of the fairness and efficiency 
of the patent system.  
Not surprisingly, however, total detachment has not been possible. For that reason, further 
comments, insights and personal opinions have been included in the final text. 
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1  I N T R O D U C T I O N  –  P A T E N T S  A N D  I N N O V A T I O N  
 
[I]n the world’s history, certain inventions and discoveries occurred, of 
peculiar value, on account of their great efficiency in facilitating all other 
inventions and discoveries. Of these were the arts of writing and of 
printing, the discovery of America, and the introduction of Patent laws. 
—Abraham Lincoln (1809–1865) 
 
Patents protect inventions. The express purpose of the patent system is to provide incentives 
for innovation, to add “the fuel of interest to the fire of genius.”1 By providing inventors with 
exclusive rights over their ideas, innovation is thereby stimulated. Patents secure the 
diffusion of this new technical knowledge, in exchange for temporary protection opposite to 
secrecy and free-rider behavior. By providing informational access to innovations, patents 
collaborate greatly to increase the social knowledge base and foster progress, by proverbially 
permitting others to “stand on the shoulders of giants.”  
With the increase of innovation and technological advancements, economic development is 
assured. Patent protection is, thus, a market incentive.2 However, in recent years, patents 
have overextended their basic function of protection and have, in their own right, become an 
important source of market power, providing not only the means to defend against 
infringing products, but a basis for business valuation.3 And, whether desirable or not, the 
patent system is becoming an increasingly important factor in global competitiveness. 
                                                   
 
1 This quote, and the one at the top of the page, are from Lincoln, Abraham, Second Lecture on Discoveries and 
Inventions, Jacksonville, Illinois: February 11, 1859, 
http://teachingamericanhistory.org/library/index.asp?document=2508 (accessed June 4, 2011). 
2 Baumol, William J., Free-Market Innovation Machine: Analyzing the growth miracle of capitalism (Princeton: 
Princeton University Press, 2002), 133. 
3 European Commission, Green Paper on Innovation (Brussels: European Commission, 1995), 14. 
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As the technological pace of change accelerates, potential inventions are increasing in 
complexity. Interrelations between technologies and rapid obsolescence provide further 
challenge to patent systems, decreasing the value of the protection granted in certain 
changing fields. The ICT market is particularly disrupted by certain impediments to 
innovation—which ironically, in some cases, are indirectly caused by the patent system. 
All with all, the permanent goal of patent systems is to increase creativity and innovation, 
which are crucial to boosting technical advancement and economic growth. 
1 . 1  S C O P E  O F  T H E  S T U D Y  &  O R G A N I Z A T I O N  
Intellectual capital will determine tomorrow’s economy. The patent system, as guarantor of 
the protection of ideas, is indeed playing a critical role in the global technological market.  
This project examines how the patent system works but, above all, is an analysis of how the 
patent system affects—and is affected by—the current global economic setting, the rapidly 
changing technological context of the ICT market, the legal and regulative framework, and 
social debate. The diverse issues considered relevant to the study became evident during the 
research process, and reflect and justify the multidisciplinary approach used. 
The focus will therefore be on the main challenges facing the use of the patent system in the 
ICT market in the different areas abovementioned: legal uncertainty, the social principles of 
the patent system, the competitiveness of the ICT industry, and technologic innovation. 
The goal of the present study is to contribute to the ongoing debate on the convenience and 
usefulness of the patent system in a high-complex technology framework, while suggesting 
out points of departure for regulatory bodies to implement further legal adaptation to the 
characteristics of the ICT field. 
The report has been mainly structured to demonstrate the two conflicting aspects present in 
patent systems, individual rights and public interest. The legal aspects of the rights conferred 
by patents concern the first part. The second part has been structured following the 
separation between the various disciplines that concern the study. 
Chapter 2 addresses the legal aspects governing patents and patent systems. There are more 
IP rights, but patents really have a privileged position underpinning the economy, and are 
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therefore studied. A typical granting process line is used to present the contents of the 
chapter: from the formal and subject requirements of a typical examination, to the outlining 
of the final right based in the patent claims. Specific legal issues are also addressed. Finally, 
the actual administrative process of patenting is presented. 
Particular problematic issues concerning patent systems are presented in Chapter 3. The 
historical evolution of patent systems is traced, from the fifteenth century to later, more 
recent events. The ‘balanced model’ governing patent systems is depicted, with a special 
emphasis on noting the inherent and extrinsic challenges and flaws affecting the 
performance of the system. Some of these extrinsic effects are described in this same chapter, 
both macro- and micro-economic—from global markets to business strategy. 
Chapter 4 gives a more precise insight on the current technological setting. It focuses on the 
specific case of ICTs and the market related to them. Particular issues hampering innovative 
processes in certain technologies are addressed, as well as particular cases of protection. 
Lastly, the consequences of the ‘one-size-fits-all’ approach in the technical field are analyzed.  
Finally, Chapter 5 explores some future implications for the patent system as related to 
different disciplines, summarizes the study, and draws out the final conclusions. 
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2  L E G A L  A S P E C T S  
2 . 1  I N T E L L E C T U A L  P R O P E R T Y  A N D  P A T E N T S  
Property is the right to own, use and prevent others from using something. Intellectual 
Property (IP), in the same line of though, is the exclusive right authors retain over the 
knowledge they create. IP is a system to protect intellectual creation with commercial value, 
and to prevent others to use it without permission.  
The immaterial nature makes IP a strange form of property to say the least. Knowledge and 
information is inherently non-exclusive (as it is not possible to deny the use of the good to 
the ones not owning it) and non-rival (the use of the good do not exclude or reduce its 
content), thus permitting the exploiting of others’ creations. Ideas may be difficult to 
produce, but are cheap to copy. So, a system of protection for ideas was established. IP rights 
transform knowledge into an exclusive good, therefore authorizations are needed to use the 
information protected. 
IP rights are divided into two categories: industrial property, which includes patents, utility 
models,4 trademarks and industrial designs; and copyright, which includes literary and 
artistic works of any kind. Further information of the different types of IP is available at 
Annex L. 
2 . 2  P A T E N T S ,  I N  B R I E F  
A patent is a type of IP consisting on a juridical title protecting an invention. The concept of 
patent will be exhaustively covered throughout the chapter, but for a better understanding of 
the following sections, patents will be briefly introduced. 
 
                                                   
 
4 ‘Utility models’ protection is not recognized in all countries. Other names for the same protection are ‘petty 
patents’ and ‘little patents.’ Not to confuse with ‘utility patents,’ which is the actual name of patents in the US. 
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Rights conferred 
Patents confer their owners the exclusive rights over their inventions: mainly, to prevent 
third parties not having the owner’s consent from the acts of making, using, offering, selling, 
or importing the product protected—or products obtainable by the process protected. The 
inventions eligible for patent protection should comply with certain requirements: being 
novel, involves an inventive step, as well as being industrially applicable. 
The right of exclusion is offered to the patent holder in return for disclosure of the particular 
innovation, which in turn assures the inventor to exploit the invention, ensure scientific 
disclosure and avoid secrecy. 
Limitations  
The 20-year period of protection begins when the patent application is filed at the patent 
office. However, the grant of the patent usually takes 2–4 years, but the patent owner may 
obtain retroactively compensation from the moment of filing of the patent application. 
Protection ends if the renewal fees are not paid, or the patent is revoked. 
Patents are only valid in the country where the patent is applied. For protection in more than 
one country, patents must be filed in the other national patent offices defined by the 
applicant.  
Patents ensure their owners exclusivity over commercial exploitation of the invention for 20 
years in the territory where the protection is sought. Patent owners may also permit others to 
use or distribute their invention by means of licenses. 
However, a patent does not authorize its holder to use or implement an invention, but 
merely to exclude others from using it. To actually produce a protected invention may 
require approval from national authorities in certain matters; and licensing of other patents, 
which could be needed to reduce to practice the invention.  
Likewise, when patent owners will not—or cannot—exploit their inventions, national 
authorities may grant licenses if the invention is of a special public interest. The use for 
experimental purposes, related to the invention itself, is also not covered by the right of 
exclusion granted by patents. 
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Infringement 
The scope of the protection and exclusion right of a patent is defined by the claims that 
accompanied the patent application. Claims formulate the exact aspects of the invention that 
are going to be protected—and only these aspects. 
A patent is infringed if any activity not permitted by the patent holder is covered by the 
geographic, time and substantive protection of the patent. Restrictions already mentioned 
must be taken into account. When a patent is infringed by a third-party activity, the patent 
owner may ask for the desisting of the action of infringement, and compensating of 
damages. 
2 . 3  R E Q U I R E M E N T S  F O R  P A T E N T A B I L I T Y  
In Europe, the current legislation5 establishes in its chapter II, articles 52.1 and 54–57, the 
conditions for an invention to be object of protection conferred by Patent Law. In spite of the 
short extension of these articles in the Patent Law as a whole, these precepts form the base of 
the protection system on patent rights, under the subsequent articles of the law.  
Article 52.1 contains a general description of the inventions that can be subjected to 
exclusiveness and legal protection. Patentable matter is defined as follows: “patents shall be 
granted for any inventions, in all fields of technology, provided that they are new, involve an 
inventive step and are susceptible of industrial application.” 
This definition implies the existence of three requirements for patentability: 
a. novelty, 
b. inventive step6 and 
c. industrial application. 
                                                   
 
5 14th edition of the European Patent Convention (EPC). 
6 Non-obviousness in the English and American context. See also note 23. 
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Patent legislation has traditionally collected some patentability prohibitions. Remarkably 
some inventions related to intellectual creation—such as software programs—and inventions 
related with life per se, even if fulfilling all requirements for patentability, are excluded or 
limited from it—by both the Spanish Patent Law and the European Patent Convention. 
The basic principles for legal analysis of the patentability of an invention (novelty, 
inventiveness and industrial applicability) will be covered, as the knowledge of such 
mechanisms is essential for a correct interpretation of the patent right, and to determine the 
lawfulness (or lack of) of any alternative realization compared to the exclusiveness right 
inherent in a patent. 
2.3.1 Novelty 
The first requirement for an invention to be considered patentable is novelty. It is one of the 
basics of patent systems, and a capital element of any technological achievement expecting to 
be made exclusive: inventions should be new. 
It is considered new something that is “produced, introduced, or discovered recently or now 
for the first time; not existing before.”7 As such, novelty is going to be determined by 
discovering if what is considered an invention existed before. Which seems a simple and 
inappropriate linguistic solution for the problem is, in fact, a definition very close to the legal 
meaning of the term. 
For the sake of juridical certainty required for third parties, which is one of the most relevant 
contours of an exclusive right (on the competition field), the legislator has defined, fictio iuris, 
legal limitations used to determine the novelty (or lack of novelty) of an invention. As a 
result, the EPC establishes in its article 54.1 that “[a]n invention is considered to be new if it 
does not form part of the state of the art” [emphasis added]. 
At this point, it is recommendable to take the time to define this new resource.  
 
                                                   
 
7 As defined in the Oxford Dictionary in its first meaning. 
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The state of the art 
The state of the art is the reference element with which the susceptible to patentability matter 
needs to be compared to evaluate its compliance for the requirements of novelty and 
inventiveness. 
The law defines the state of the art relative to any existent work by the date of application 
that “[t]he state of the art shall be held to comprise everything made available to the public 
by means of a written or oral description, by use, or in any other way, before the date of 
filing of the . . . patent application.”8 
There are then defined—not limitedly—two types of anteriority, which can be detrimental to 
validity of a patent application. So it seems, it should be necessary to consider novelty in 
light of everything made available to the public (in a written or oral way) previously to the 
application, and any previous use. There is no geographical limit respective to this point, 
which has not always been the rule.9 
Written and oral descriptions 
For the sake of practicability, it should be stated what commonly is considered part of 
“everything made available to the public.” Typical written descriptions considered are: 
patents and utility models documentation, published by any patent office; publications of 
any type, especially those related to the technical field corresponding to the matter of the 
patent; but, in fact, any type of documentation registered on any oral or graphic media. 
                                                   
 
8 Article 54.2 EPC. 
9 In the same sense, Spanish Patent Law, in its article 6.2 “. . . in Spain or abroad . . . .” But for previous Patent 
Law from Spain, Britain, Germany (§2 Patentgesetz 1887), and other European states it was only considered as 
prior art the disclosures and uses made in the country. U.S. Patent Law, on the contrary, still maintains the 
condition of “prior use in the country,” (35 USC, 102) provoking polemical decisions such as the granting of the 
Basmati Rice Patent. For a broader insight in this subject, see: Vandana Shiva, “The Basmati Battle And its 
Implications for Biopiracy and Trips,” Global Research, September 10, 2001 
http://www.globalresearch.ca/articles/SHI109A.html (accessed March 20, 2011). 
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Apparently, oral descriptions are also considered, even though there is a higher difficulty on 
proving their existence. Specifically, a public exposition made by the inventor or technology 
owner to others—without subjection to keeping the secret—is one of the typical cases.10 
Any document with the slightest chance of accessibility will indeed be considered part of the 
state of the art. It is not necessary to demonstrate access to the information; it’s enough to 
determine that there is evidence of the possibility of access by a third person, the public. The 
law does not contemplate if the information was more or less accessible: if any person can 
understand or transmit that information and has no obligation of keeping the secret of the 
technology, then it is considered available to the public.11 
Prior use 
Prior use of the invention could represent an obstacle for patentability if the public, by this 
means, had been granted access to the technology.12 It is usually the inventor or technology 
owner who is responsible for such acts of disclosure, i.e., rushing the product to marketing 
or commercialization. The selling of only one unit of the product or distribution of 
catalogues or client leaflets is considered damaging to the granting of an applied patent—or 
to the validity of a given one. 
Harmless disclosure 
The European and Spanish body of law depicts legal exceptions for the use of detrimental 
disclosure elements as such, even though they were collected in the state of the art from 
what it has been established previously. The solicitor has to demonstrate the concurrence of 
                                                   
 
10 I.e., PhD thesis presentations, both oral and written, which are given to the jury. 
11 Cornish, William R., Intellectual Property (London: Sweet & Maxwell, 1997), 152. 
12 I.e., as considered in the EPO Boards of Appeals’ cases T 84/83 (in which a wide-angle mirror fitted to a motor 
vehicle for demonstration purposes for six months; having the vehicle being it parked in the street or in motion in 
highways, is considered as public access to the invention) and T 245/88 (vaporizers installed in a non-restricted 
area before patent filing). 
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one of these disclosure circumstances occurred within the 6 months prior to the application 
for patentability:13 
a. an evident abuse,  
b. display of the invention in an official or officially recognized exhibition, or 
c. tests made by the solicitor of the patent, without commercial exploit. 
In determining whether a disclosure of the invention is “an evident abuse in relation to the 
applicant or his legal predecessor,” the solicitor should be required to prove the act of 
abuse—i.e., corporative espionage—and cause-and-effect connection between the abuse and 
the final disclosure alleged against him. English legislation regulates, in a more precise way, 
that the exception should be applied if the information was obtained as a consequence of a 
non-disclosure agreement violation.14 
As for the matter of exhibition of the invention in official expositions, the Spanish law is 
surely generous, compared to other European bodies of law and the EPC. For determining 
the range of harmless exhibitions, the Spanish Patent Law refers to the framework of the 
International Exhibition Convention—signed in Paris in 1928—, but nonetheless including 
others referred as “officially recognized exhibition[s].” This widening of immunity could 
lead into legal uncertainty and patentability disagreement between states, and contradiction 
with the EPC, as some authors have pointed out15. 
The last of the exceptions, working tests prior to the patent filing, is only gathered in the 
Spanish Law, and is considered for the effect of non-invasiveness of any working test made 
prior to the patent application. Anyway, these alleged working tests could never be an 
exploit of any way of the invention. 
                                                   
 
13 Article 7 SPL. 
14 Article 2.4, UK Patents Act, 1977. 
15 Gómez Segade, José Antonio, La Ley de Patentes y de Modelos de Utilidad (Madrid: Civitas, 1988), 64. 
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Although not included in the Spanish legislation, some states recognize the existence of 
another exception, called the grace period, in their patent systems.16 This circumstance consists 
of an open period of six or twelve months before the proper filing of the patent, in which the 
disclosure of the invention (by the inventor or solicitor) is permitted. Thus, for example, an 
enterprise could offer its invention in a commercial campaign, without compromising the 
future novelty of the patent. Tests of the future acceptance of the product can be made in 
such a way. European states, it should be stressed, require absolute novelty for any 
patentable invention; as such, no disclosure or prior use should be made prior to the patent 
filing in any case. 
Date of filing and prior patents’ applications 
The filing of the patent application is the temporal parameter, hereafter called the priority 
date,17 which determines both the limits of the state of the art knowledge made public before 
that moment, and the start of the rights granted by the future patent. The consideration of 
the exact time of the filing, and no other options, such as the moment of discovering the 
invention, has been widely discussed.18 Some disadvantages of this idea are: the difficulty of 
proving the establishment of that exact point of time; factual permission for later 
patentability of already commercially-proven inventions; and legal uncertainty to 
competitors. 
Therefore, the state of the art is completed with any patent and utility models applications 
filed on a previous date to the filing of the patent. Additionally, any national patent or utility 
model applications filed previous to the priority date and which were published on or after 
that date, shall be considered as comprising the state of the art of any subsequent 
application. The inclusion of this type of documents is determined fictio iuris by the legislator 
                                                   
 
16 I.e. one year in the U.S. (35 USC 102.b) 
17 Article 89 EPC. 
18 Not to lose the focus, “the final purpose of the patent system is industrial progress. Thus, the moment of filing 
is ideal for establishing the state of the art, as it is the moment in which the inventor unequivocally expresses their 
wish to publish its contents to the benefits of society. If the society had by any other means access to that 
information, it would not be necessary to grant an exclusive right.” Vidal-Quadras Trias de Bes, Miguel, Estudio 
sobre los requisitos de patentabilidad, el alcance y la violación del derecho de patente (Barcelona, J.M. Bosch Editor, 2005), 
44. 
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(not published in that date, these documents should have been excluded by the article 54.2 
EPC). Notwithstanding, for reasons affecting double-patenting of a certain invention, this 
exception helps maintaining legal certainty. A close reading of the article 54.2 indicates that 
further application of previous patent filings into the state of the art must be conditioned to 
their actual publication. I.e., a patent application withdrawn or not conceded, which has 
been kept in secret, should not be included in the state of the art. 
Despite the exceptions exposed, the fact remains that in patent priority the principle of first to 
file is generally applied.19 
Henceforth 
Having presented the concept of the state of the art, determining novelty is not only a matter 
of recovering what was stated in the prior article 54.1 EPC—“[a]n invention shall be 
considered to be new if it does not form part of the state of the art.” 
This definition, which informs the interpreter of the patent what elements will determine if 
the invention is anticipated (and so its novelty), is not free of interpretative problems. More 
often than not, the solution of these problems will be spotted in the specific context for each 
assumption of patentability. Yet, to make things worse, these parameters are meant to serve 
agents or jurists in examining an eminently technical situation, which will not always be 
within their expertise. Therefore, as a general rule, it will be necessary for an expert in the 
field (or person skilled in the art) to assist them. The ‘expert in the field’ conception will be 
discussed in section 2.3.2. 
The variety of eventual documents to consider—taking into account the absolute principle of 
novelty stated in the law—makes it impossible to cover every potential anteriority existent in 
the world. From a practical point of view, no registry system—electronically managed 
included—is capable of registering the complete extension of available information. The 
                                                   
 
19 U.S. patent system is currently based on the first-to-invent principle. There has been debate in this matter for 
ages, and is still not resolved at the time of writing—the Patent Reform Act of 2009 (S. 515/S. 610/H.R. 1260), still 
not voted by the U.S. Senate, argues for a change to a first-to-file system. 
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norm can only establish the external limit of the actual search activities of patent 
authorities.20 
As such, novelty of an invention should be determined based upon an objective comparison 
with every priority cognizable by the public. This analysis must come from individual 
comparison between the invention and every component of the “state of the art,” attending 
only to its content.21 Determining whether the content of the invention was previously 
known will become the question established as the juridical finality of the novelty exam.22 
To sum up, an invention lacks of novelty if any element or stage, including any implicit 
characteristic for an expert in the matter, is disclosed in a single element of the state of the 
art. 
2.3.2 Inventive step23 
The inventive step is the second requirement for determining patentability of an invention—
as paradoxical as it may seem. Article 56 EPC includes a definition of the concept: “[a]n 
invention shall be considered as involving an inventive step if, having regard to the state of 
the art, it is not obvious to a person skilled in the art.” Three conditions for inventiveness 
may arise from its content: 
a. “having regard to the state of the art, 
                                                   
 
20 Grønning-Nielsen, Leif, “Concept of Novelty,” International Review of Industrial Property and Copyright Law 22 
(1991): 929. 
21 EPO, Guide for Applicants, B.2 §32. 
22 It would not be licit to use a combination of documents to determine if an invention is new, as it will be the 
scope of the inventive step (or non-obviousness) valuation. 
23 In Europe (both national case law and EPO procedures), this requirement is called inventive activity, inventive 
step or inventive highness (Erfindungshöhe in the German patent system). In the British and U.S. systems, on the 
other hand, it is stated that the inventions should be non-obvious. As it would be further discussed in this chapter, 
each of these definitions are considered in the determination of this requirement by different possible patent 
examination. In the same direction, the TRIPS agreement, adopted by the WTO in 1994, which purpose is to 
harmonize IP application processes worldwide, states in its article 27 that, to the effects of requirements for 
patentability, “the terms ‘inventive step’ and ‘capable of industrial application’ may be deemed by a Member to 
be synonymous with the terms ‘non-obvious’ and ‘useful’ respectively.” 
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b. it is not obvious 
c. to a person skilled in the art.” 
Boundaries between novelty and inventiveness may be confusing at first sight. So to speak, 
appreciation of the latter is subsidiary to the existence of the first: lack of novelty will 
preclude absence of inventiveness—as the invention will obviously be covered in one 
component of the state of the art. Nonetheless, current legislation provides no doubt over the 
differences between the juridical nature of the two. 
Hence, as it has been previously stated, for determining novelty, it only requires finding out 
if the invention was described as such in the previous state of the art. For determining 
inventiveness, on the other hand, it would be necessary to determine if the expert in the 
matter, from the same prior knowledge and their own, could obtain the same result, in an 
obvious way. 
In addition to this, the documentation that constitutes the state of the art is different in case 
of determining novelty or inventive step. Article 56 EPC excludes the consideration of prior 
patent applications being presented before the one examined, but not having been 
published. Those documents were included previously in the state of the art,24 to the effects 
of considering whether an invention was new—as seen in section 2.3.1. The reason for this 
exclusion now is logical: although those applications were considered for avoiding 
duplication of patents, there is no justification in the use of these patent applications for 
analyzing inventiveness, as there has been no public access to them at the time of the filing. 
Moreover, the requirement of inventiveness, as compared with determining novelty of an 
invention, has an element of uncertainty due to the subjectivity of this examination. The 
source of this subjectivity is the practice of this so-called expert or person skilled in the art. This 
concept of a juridical fictional character should be examined for a clearer view. 
 
                                                   
 
24 Which, should it be remembered, were artificially included in the state of the art. 
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The person skilled in the art 
The law leaves in the hands of this fictional character, created by the legislator, ‘the person 
skilled in the art’—or ‘expert in the field’—, the labor of interpreting whether if the invention 
results in an obvious way from the state of the art.25 The first practical question that comes 
into the mind is who could be considered a person skilled in the art; that is to say, the 
knowledge and skills he or she needs to be considered as such. Current law does not depict 
these answers; precedential legal cases and academic opinion will be the principal sources of 
definition. 
The expert should be ‘skilled in the art’ in matters related to the invention. This is an 
important affirmation, as even if the documentation considered to exam non-obviousness is 
defined as unlimited geographically and temporarily (backwards) by the law, the condition 
of “person skilled in the art” is intrinsically a limitation. 
About the knowledge of this fictional character, applicable case law seems to consider the 
expert to be a middle technician in the relevant matter.26 The expert, then, needs to be neither 
the ordinary worker nor the high-qualified professional; but, in my opinion, given today’s 
complexity in some technology fields, something more than an experimented technician 
would be required to understand the invention and put it into practice—as stated in article 
83 EPC. One way or another, they are supposed to read the relevant literature attentively, 
showing an unlimited absorption capacity, but no inventive skills.27 
Finally, due to current interdisciplinarity in technical fields, determining the person ‘skilled 
in the art’for evaluating an invention involving the expertise of different fields is not as 
                                                   
 
25 The expert in the field or person skilled in the art is cited in the EPC in Arts. 56, 69, 83, 100b, 138.1b, Rule 31, and in 
the protocol of interpretation of Art. 69. As for the Spanish Patent Law, the expert is present in Arts. 8, 25, 112.1b). 
26 “French, German and British experiences define the ‘expert in the field’ as a middle technician of the considered 
sector. He is the ‘Durchschnittsfachmann’ in German Law, the ‘the man ordinary skilled in the art’ of British Law, 
‘l’homme de métier moyen’ . . . of French case of law.” Mousseron, Jean Marc, Traité des Brevets, (Strasbourg: 
LITEC, 1984), 393. 
27 As stated in the EPO Court of Appeals’ case T 39/93 (OJ 1997, 134), “whilst generally accepted definitions of the 
notional ‘person skilled in the art’ did not always use identical language to define the qualities of such a person, 
they had one thing in common, namely that none of them suggested he was possessed of any inventive 
capability. It was the presence of such capability in the inventor which set him apart from the notional skilled 
person.” 
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simple as selecting a middle technician. In this case, the figure of the expert is formed by a 
group of skilled people in the relevant matters, configuring the legal concept of expert in the 
field. This is the actual configuration of expert teams working in complex fields, i.e. 
biotechnology, and such a figure is established in the EPO directives.28 As such, the juridical 
fiction adapts to reality, and the character is supposed to have the knowledge required for 
determining patentability. 
These guidelines represent basic conditions for an expert to satisfy its work; such an expert 
should be a good documentalist, consider the existing elements under the light of the 
applied invention and assess its degree of originality. Every single one of the conclusions 
attained should be based only in elements comprised in the state of the art. 
Valuation of inventiveness 
The experts in the field must meet certain specific characteristics. It is also essential to 
determine the extent of their functions as well as the procedural aspects of in their job.  
Essentially, the expert must establish whether the object of the invention results from the 
state of the art in an evident way. As pointed out before, this exam is made after determining 
that the invention is not described in the state of the art and it is considered new. In this 
second stage, the expert focus will be to state if the solution was obvious, given the prior 
information to the filing date of the patent and his/her own knowledge. In other words, 
valuation of inventiveness entails determining if the expert would have arrived at the same 
conclusion as the inventor has. 
To analyse the inventiveness (or non-obviousness) of the invention, the person skilled in the 
art will not use the documents or prior disclosures in an isolated way (as it has been done 
before when valuing novelty); on the contrary, he or she will combine this documentation to 
                                                   
 
28 These appropriate circumstances happened in cases T 141/87 and T 99/89 of the EPO Court of Appeals. 
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determine if, as a whole,29 it hosts sufficient information to sustain the obviousness of the 
invention, without resorting to the inventor’s disclosure. 
Problem and solution approach 
European examiners almost always use this system in valuation of inventiveness, with the 
objective in mind of adopting homogenized criteria—and so assuring legal certainty.  
The problem and solution approach consists, basically, of a three-step execution:30 
1. determining the closest prior state of the art,  
2. establishing the "objective technical problem" to be solved, and  
3. considering whether or not the claimed invention, starting from the closest prior art 
and the objective technical problem, would have been obvious to the skilled person.  
After carrying out these three actions, the examiner normally has the capacity to determine if 
the expert would have modified or adapted the previous elements of the state of the art to 
reach the same result of the invention. As stated in the EPO directives, the problem and 
solution approach is the recommended system of examination, but is not mandatory.31 
Henceforth 
As seen before, the requirement of inventiveness is not shown by the mere fact that the given 
solution never occurred to anybody. An invention is not obvious for an expert in the field 
unless it unmistakably results from the state of the art. 
                                                   
 
29 “Obviousness is judged by viewing the invention as a whole against the state of the art as a whole.” Cornish, 
Intellectual Property, 169. 
30 EPO, Guidelines for Examination in the European Patent Office (Munich: EPO, 2010), C-IV, §11.5. 
31 “In principle . . . the problem and solution approach is to be used; however, if exceptionally some other method 
is adopted, the reasons for departing from this generally approved approach should be stated.” Case Law of the 
Boards of Appeal 6th Edition, (EPO, 2010), I.D.2. 
T H E  P A T E N T  S Y S T E M  I N  T H E  G L O B A L  I C T  M A R K E T :  A  C R I T I C A L  A N A L Y S I S  33 
2.3.3 Industrial application 
The third and last requirement for patentability is the capability of industrial application, “if 
it can be made or used in any kind of industry.”32 This includes agriculture and, potentially 
more interestingly, services. It seems rather obvious that almost all technical inventions 
satisfy this requirement.33 
This last requirement for inventions to be patented, industrial applicability, is considered as 
such in the national European Patent Systems, and the EPO. . The latter, however, considers 
inventions as “technical solutions for a technical problem.”34 
In the US, the industrial application is not taken into account: to be patentable, inventions 
should be useful.35 It is not compulsory for an invention, then, to have an industrial use, or 
provide a “technical contribution.” This fact provides a legal base to admission of 
controversial patentable matter in the US, i.e. business methods. 
2.3.4 Not patentable matter 
Solicitors may apply for patent protection for any invention in any field of technology36 
provided they meet the requirements for patentability already presented—that is, novelty, 
inventive step, and industrial applicability.  
The same law does not provide with a definition for ‘invention,’ but in any case provides, in 
the article 52.2 EPC, a non-exhaustive37 list of what is not considered an invention. The items 
                                                   
 
32 Article 57 EPC. 
33 Except for inventions of typically not patentable matter; complicated instances such as sequences of genes, 
whose utility are not always obvious; and those violating Physical laws, such as machines functioning generating 
more energy than they need—also known as perpetual motion machines—, which are not capable of functioning 
whatsoever. 
34 Industrial applicability does not appear as an independent article. It is discussed instead in the EPO’s Guide for 
Applicants, §B.27. 
35 About European and U.S. terminologies, and how the TRIPS harmonize them, see note 23. 
36 Art. 52.1 EPC 
37 So-called ‘non-exclusive’ in EPO, Guide for applicants, B.I. 
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are either abstract or non-technical. As a rule, it can be said that inventions must be both 
concrete and have a technical character.38 
The following are not considered inventions by the European law—and therefore not 
susceptible of protection: 
a. Discoveries,39 scientific theories40 and mathematical methods;41 
b. aesthetic creations;42 
c. schemes, rules and methods for performing mental acts, playing games43 or doing 
business,44 and programs for computers;45 
d. presentations of information.46 
                                                   
 
38 Which complies with the further requirements depicted in EPO, Examination Guide, C.IV.1.2.ii: “The invention 
must be of ‘technical character’ to the extent that it must relate to a technical field, must be concerned with a 
technical problem, and must have technical features . . . .” 
39 Mere discoveries of new properties from materials do not qualify as inventions according to article 52.1 EPC, as 
they are already existing matter not having a further technical effect. On the contrary, if the property is put to 
practical use, it constitutes an invention that may be patentable. Discovering of genes and microorganisms in 
nature with a technical effect are also patentable by the European patent law—see also section 4.6.1. 
40 Scientific theories are essentially a more general form of discoveries. 
41 A mathematical method is an example of a perfectly abstract method. 
42 Aesthetic objects are creations having aspects essentially related to subjectivity and normally different from 
technical objects. Industrial designs and copyright may protect these creations. However, if these objects have any 
technical features they can be patentable, even if the aesthetic effect is not—i.e., a new type of binding for a book, 
which also has an aesthetic effect. 
43 All of them abstract methods. 
44 As such, business methods are intentionally excluded from patentability. However, if a technical process can be 
specified, it then may be patentable—see also section 4.6.3. 
45 Computer programs are not patentable ‘as such’ (differentiation present in art. 52.3 EPC), but are not excluded 
automatically from patentability (EPO, Applicants’ Guide). However, they are not excluded if causing a further 
technical effect occurring beyond the interaction of program (software) and computer (hardware). Computer 
programs patentability will be widely discussed in section 4.6.2. 
46 Presentations of information are solely based on the content of the information, and are deemed not 
patentable—presentations per se or processes for presenting information (EPO, Guide for applicants). Other types of 
protection, such as copyright, already cover them. 
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In addition to the above-listed items, Patent Law may also explicitly exclude some scientific 
and technical fields, whose inventions are not patentable. This not qualifying matter is 
considered an exception to the rule, and is essentially determined by the patenting office to 
which the application is addressed. Thus, patented inventions for the USPTO may not be 
patentable at all at the EPO. 
Article 53 EPC lists the matter excluded from patentability: 
a. Methods of treatment of the human or animal body—surgery, therapy or diagnostic 
methods;47 
b. plant or animal varieties, or biological processes for the production of both;48 
c. and inventions deemed contrary to morality or ‘public order.’49 
The different national and regional offices have different standards regarding to what is 
considered an invention, and what matter is deemed not patentable. 
2.3.5 Formal requirements 
The requirements for the presentation of a patent application in any of the different national, 
regional or international offices are essentially analogous. That said, the documents needed 
for applying for patent protection are briefly presented.  
 
                                                   
 
47 This rule does not affect pharmaceutical products. These substances have a special treatment as regards to 
novelty requirements (art. 54.5 EPC): “even a known substance or composition may be patented for further 
medical or veterinary uses, provided that such use is novel and inventive.” 
48 But not affecting to microbiological processes or products; in general, if a technical process is used to isolate 
biological material it is patentable. In the case of plant varieties obtained from crossing of selection, a separate 
form of protection is available in most contracting states and under EU law. 
49 The EPO, in particular, underlines the following: methods for the cloning of human beings, process for 
modifying the germ line genetic identity of human beings, use of human embryos for industrial or commercial 
purposes, and processes for genetically modifying animals that are likely to cause them suffering without any 
(substantial) medical benefit. Also, ethics of gene patents will be addressed in section 4.6.1. Other inventions 
considered to be contrary to ‘public order’ are weapons contrary to war- and anti-terrorist- treaties, such as letter 
bombs. 
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Contents 
In the case of patent filings at the EPO, article 78 EPC sets out the documents the application 
must contain:  
a. “a request for the grant of a patent [European, in this case]; 
b. a description of the invention; 
c. one or more claims; 
d. any drawings referring to the description or the claims; 
e. an abstract of the invention.” 
Further provisions are stated—in the case of the EPO—in the implementing regulations,50 
which further contour the characteristics of these elements.  
Special attention will be drawn towards the disclosure make in the description and the 
claims, which are the key factor to the protection conferred by theresultant patent granted. 
Description, drawings and claims will be addressed in the following section. 
2 . 4  P A T E N T  C L A I M S  &  I N F R A C T I O N S  
2.4.1 Patent claims 
The essential element which configures the economic framework of patents’ rights is the 
tension between the patent holder interests—who benefits from the exclusive right because 
of a technical advancement provided to society—and those of the third-parties affected by 
the existence of this right and that are going to be deprived of space for technical growth. 
The state,51 as grantor and protector of patent rights, is responsible for merging the particular 
interests of individual patent holders and the competition, without losing sight of the general 
                                                   
 
50 Implementing Regulations to the Convention on the Grant of European Patents, part of the EPC. 
51 Analogous to the national patent offices, this analysis is valid for supranational organizations. 
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principle of boosting innovation: disclosing the technical information of new inventions. At 
the same time, the national administration is also granting juridical certainty to what third-
parties can do when accessing the information. 
These patent holder’s interests are articulated in the patent application and more specifically, 
in the claims, configuring the reach of the exclusivity right. 
Claims as scope of patent rights 
For a correct interpretation of what constitutes the object of a patent right and its juridical 
consequences—in terms of actual applicability in legal litigation—, the legal interpreter starts 
with a predetermined factice initial situation. This initial situation is determined by the reach 
of the object of the right, configured in the claims of the patent application. The analysis at 
this stage is taken strictly at the written facts, avoiding outside elements, thus using the 
application as it was submitted. 
Patent claims are, therefore, the essential core for determining the protection granted to a 
patent holder. It is in the claims where the constitutive elements of an invention are detailed 
in the way the patent applicants want to guarantee their exclusivity. 
Structure of claims 
Claims are essentially made of two distinct parts: the preamble, which presents the object of 
the invention (the preamble does not configure the patent protection object as such; it has to 
be complemented by the technical disclosure of the invention), and the technical elements, 
which expose the inventive parts. The two parts are usually united by one of the typical 
grammatical elements, such as ‘comprising,’ ‘said device comprising,’ ‘characterized in.’ 
Indeed, the invention definition consists in the sum of the two parts, and each is equally 
important to configure the scope of the right. 
Dependent and independent claims 
Patent claims can be distinguished by comparing their level of sufficiency to define an 
inventive idea, essentially, whether its text does not refer to prior claims. The type of claim 
not containing any references to others is known as independent claim. Whereas claims that in 
their preamble refer to other claims and add additional limitations in the characterizing part 
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are referred to as dependent claims or ‘particular embodiments,’52 and they are normally 
used to cover realizations of the invention specifically useful. 
Product, process and use claims 
Practice has traditionally distinguished between different types of claims, depending on 
what was the nature of the object of protection. To simplify, one could consider these three: 
product, process and use claims.53 The most important characteristics of every kind of claim 
will be discussed. 
‘Product claims’ represent protection over a product, apparatus or substance, resulting from 
the invention, independently of the specific process used to produce it, and the further use of 
the given physical entity.54 Thus, the patent holder has a priori a broader protection for its 
invention: by this means, an identical product in the territory of designation of the patent is 
sufficient base for patent infraction, and legal actions may be taken. 
The second category of claims, ‘process claims,’ covers all every kind of method, process or 
manufacture for obtaining a given product or substance, or which requires some material 
product. This definition also includes the activities upon other processes, i.e. control 
processes.55 
                                                   
 
52 EPO Examination Guide C.III.3.4. Also, CHISUM proposes the separation between dependent claims, as 
integrating the limitations of the previous claim it makes reference to, and multiple dependent claims, which 
refers alternatively to two or more claims, and is considered to include all limitations in every referenced claim 
and itself, as defining elements of the claim. Chisum, Donald S., et al., Principles of Patent Law: Cases and Materials 
(New York: Foundation Press, 1998), 87. 
53 It is also considered in the different national laws, with variations in the number of categories: TRIPS 
distinguish between 2 types, while the EPO essentially distinguish between claims over physical entities and 
activities, but refers to the third—use—, at the EPO Examination Guide C.III.3.1. 
54 As obvious as it may be at this point, product claims demand specifically the three patentability requirements—
new, non-obvious and industrially applicable. As such, traditionally a product claim was not desired to patent 
already-known products with new effects added by the process used to manufacture them, i.e. pharmaceutical 
and biotechnological products. A product-by-process claim was the answer to these situations. Today, patent 
systems such as the EPO establish that this type of claims is only allowable “if the products as such fulfil the 
requirements for patentability” (Examination Guide C.III.4.12). So, independently of the phrasing ‘obtainable’ or 
‘obtained,’ product-by-process claims confer basically absolute protection to the product; irrespective of the 
process described to make it. 
55 EPO Examination Guide C.III.3.1. 
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If the product obtained by a process protected by a process claim fulfills all requirements for 
patentability, then protecting the product itself should be recommended itself.56 After all, 
legal enforcement of infringement of process patents is presumably harder to accomplish. 
Proving that a given product, which is being used or marketed, is obtained by a patented 
process is almost impossible.57 For that reason, the European law resolves that its members 
must invert the burden of proof.58 I.e., in case of existence of a product A allegedly equal to a 
product B resulting from a process protected, it is the creator of product A who should prove 
that its manufacture does not infringe the patent. Being so, further legal dispositions are 
made to prevent the misuse of probatio diabolica to provide patent owners a way of industrial 
espionage of competitors. 
The last of the basic type of claims is the ‘use claim.’ Innovation could come in the form of 
new products or processes; but it is also possible that the new and inventive character comes 
from the unknown use of these already-known products or processes in a different technical 
field.59 However, use patents are considered by the EPO essentially as process patents, in 
which the desired purpose is accomplished by the use of the given product or process.60 
It is important to emphasize that, irrespectively of the type of claim an inventor refers in his 
or her patent application, some inventions would require claims in more than one category 
for full protection of the idea. 
  
                                                   
 
56 See note 54. 
57 And certainly the means to achieve any prove of process infraction are probably illegal—it would require, at 
least, having access to the production methods of the infringer. 
58 Article 75 of Luxemburg Community Patent Convention. 
59 35 USC, 101. An example of this type of claim could be patent US Patent 2600668: new use for the DDT—an 
already known product in 1952—as an insecticide. 
60 As considered in the EPO Guide C.III.4.16. Following the previous example: a use claim such as ‘the use of DDT 
as an insecticide,’ is equivalent to a process claim such as ‘a process of killing insects using the substance DDT.’ 
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Unity of Invention 
As a general rule for patent offices, patent applications must relate to a sole invention—or, in 
some cases, it is permitted to relate a group of inventions forming a single general inventive 
concept.61 This requirement is called ‘unity of invention.’ 
Following this motivation, no more than one independent claim could be made in the same 
category—product, process or use. However, in the case of the EPO, following its particular 
ruling of unity of invention, multiple independent claiming is allowed, in the cases 
presented at Rule 43.2—that is, a plurality of interrelated products, different uses for the 
same product, or alternative solutions to a particular problem, when it is difficult to cover 
them all in one claim.62 On the other hand, the USPTO has stricter requirements for unity of 
invention, and would rather ask applicants for different patent filings for the same European 
patent application.63  
Broad claims’ usual expressions 
Wherever possible, patent applicants will like to introduce open expressions in the definition 
of its inventions. The interest behind this action is that, given an exclusive right over the 
patented object, they could maintain its exclusivity over a broader range of elements—
legally, everything a ‘person skilled in the art’ could understand as comprised in the 
disclosure.64 
It is not unusual in the writing of an application of a patent to keep the identification of the 
elements defined in a claim relatively open,65 for example, providing a quite broad number 
of possibilities from the same elements included. In the American patent practice, these types 
                                                   
 
61 Article 82 EPC and Rule 44 EPC. 
62 This exception to the rule is mostly used in chemical patenting, when comparing products in their intermediate 
and final stages (where they have the same essential structural element, and the final product is closely inter-
related with the intermediate or it is manufactured directly from the other). 
63 WIPO, Summer School on Intellectual Property (Geneva: WIPO – UNIGE, 2010), 22. 
64 Further discussion on the strategic filing of broad claims is discussed in section 3.5.1. 
65 And open writing of claims could be as convenient as dangerous. It is contrary to the clarity and completeness 
that the law requires. 
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of expressions are called means plus function elements,66 i.e., defining the union of two pieces 
from ‘screwed’ or ‘glued,’ which are quite limiting, to ‘fastening means.’ By using the 
expression ‘fastening means’ the applicant adds to the claim reach a wide range of other 
variants; these variants could cover many interpretations any third-party reading the patent 
disclosure—and some of them possibly never considered by the applicant. This type of 
generic formulae creates interpretation problems; for instance, when a given realisation of an 
element defined by a means plus function uses a mean not known at the date of filing.  
In the same way there are other practices in claim writing used to specifically broaden the 
object of protection. More or less evident variants of an element could be included using a 
so-called omnibus expression. I.e. ‘about’ or ‘approximately,’ used with any numerical 
quantities or lengths, could mean that not only the indicated numbers are protected, but also 
its variations—included in what could be considered operational by a person skilled in the 
art. Or ‘plurality,’ rather than simply saying ‘two’ or ‘three.’67 Other omnibus expressions 
specifically refer to the multiple variations of the method of a claim by constructions such as 
‘substantially as described’. There are many more examples of these ‘tricks’ in the 
literature.68 
The range covered by omnibus expressions can be subject of quite different interpretations in 
national courts, so its use varies from ‘discouraged’ to ‘not accepted’ by some patent offices, 
such as the EPO. In many cases, the final decision would be held in court if the patent was 
challenged. In my opinion, the practical inconsistency of the omnibus expressions affects 
negatively to the legal certainty of both applicants and third parties—any doubts on the 
scope of the patent may cause legal uncertainty. 
Description and drawings 
As previously discussed, patent claims should be written with clarity and precision, as stated 
by the law and for the patent holder best interest. The description itself provides an extended 
                                                   
 
66 DeMatteis, Bob, Gibbs, Andy, Neustel, Michael, The Patent Writer: How to Write Successful Patent Applications 
(New York: Square One Publishers, 2006), 107. 
67 DeMatteis, Bob, Gibbs, Andy, Essentials of Patents (New Jersey: John Wiley and Sons, 2003), 89. 
68 EPO Exam Guide C.III.4.6–7 provides other examples: ‘start,’ ‘until there,’ ‘short,’ ‘long,’ ‘high,’ ‘strong,’ ‘soft.’ 
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explicative definition of the invention, and is usually complemented by a certain number of 
drawings.  
Description and drawings, as such, do not constitute any right object by themselves; 
however, the function of these elements is to help in the interpretation of the claims. Their 
use is necessary to understand the meaning of certain expressions that may be unclear but in 
no case a description should be used to increase the scope of the claims towards elements not 
previously protected. 
The description provides information to the reader about the purpose of the invention and 
its technical field. The technological context is also given, covering both the approach of the 
existent technical problem and the solution proposed. To complete the description, one 
invention realization must be depicted, illustrated by examples and drawings.69–70 
One of the basic requirements of every patent system is the disclosure of the invention in a 
way that is sufficiently clear and complete for an expert in the field to perform it—namely 
sufficient disclosure.71 Insufficient disclosure prevents the granting of a right over an object. 
Non-sufficient disclosure is indeed one of the reasons of nullity of a patent.72 
Therefore, sufficient disclosure is a requirement to the solicitor of a patent right, for three 
different reasons: one, writing clear and complete claims complemented by the description 
and drawings is a legal liability; two, it is in the best interest of the holder of the patent to 
sufficiently define the reach of its right for a good protection; three, clearly defining the 
object of protection in the disclosure is extremely important for the legal certainty of third 
parties.  
                                                   
 
69 Rule 42 EPC. 
70 It is not within the scope of this study to provide an exhaustive guide of the different elements composing the 
patent. For further information on drawings and their format one can refer to the EPO Guide for applicants. For 
the US special formats, Bryant, Joy L., Protecting your ideas: The Inventor’s Guide to Patents (San Diego, Academic 
Press, 1999), 148 
71 Art. 83 EPC and EPO Guide for applicants C.II.67-68 
72 As is for example covered in the SPL, arts. 35 and 112.1.b. 
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2.4.2 Patent infraction 
As said before patents are concession of rights, defined by the claims of the application. It is 
now time to discuss the legal reach of patent rights and the tools that can be used by patent 
holders to enforce unauthorized use of their inventions. 
Essentially, patents are administrative acts73 of constitution of a right to favor a private entity 
against third parties—via a beneficial position on a market. As such, this administrative act 
has two main effects over the rights of both the applicant and thirds. First, an enlarging effect 
over the juridical sphere of the beneficiary of the patent grant, as he or she has now the 
exclusivity of use of an invention. And secondly, it has a limiting effect of the juridical sphere 
of third parties, which are restricted on the use of the protected invention, which is 
prevented by the patent. 
Patents provide their holders with the right to prevent any other person to use, manufacture 
or commercialize the protected inventions. Infractions of this right are enforced exclusively 
at national courts—as patent are territorial rights. 
It is worth mentioning here that national courts work under the presumption of validity of 
the patent right in court. However, it is also true that rights conferred by patents are not 
guaranteed by the nation states: they have to be defended by the patent holder in case of an 
eventual infraction or legal challenge. 
At court, in order to determine whether or not a competitor or third is infracting the 
exclusivity of the patent holder, a two-step process is required: 
1. determining the reach of the right conferred by the patent, 
2. studying the link between the objective elements related to the right74 and the specific 
use the third party made, to determine if it is indeed an infringement of the patent. 
                                                   
 
73 In this case, patents are administrative acts from National Patent Offices. 
74 The objective elements include the state of the art, the date of filing, the concept of ‘person skilled in the art’ 
appropriate to the invention and, of course, the claims. 
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These steps require both legal and technical treatment: judges and technical experts will need 
to collaborate in cases of a certain complexity—the latter only to provide their knowledge, 
never at the point of decision-making. Of course, judges are the only ones making the final 
verdict. 
Defining the reach of patent rights 
The most common legal interpretation of patent rights in the US and Europe is the 
interpretation of a patent as any other legal text or law. This single interpretation guarantees 
a unity of criteria and legal certainty. This is the reason courts have opted for a law 
interpretation of the patent rights over contractual interpretation. 
Criticism has been raised against the interpretation of patent rights under the scope of 
contract law, arguing that contracts bind the two parts and have no effect against third 
parties. In the case of a patent, the parts of the contract are outlined as the inventor or 
applicant and the Administration; the physical or juridical persons of the territory are 
entities out of the contract and, therefore with no legal compliance.  
It is a point of view shared with several authors,75 that the exclusion of third parties is not 
sufficient reason to deny application of contract law to interpretation of patent rights, and 
that its use has some benefits in itself. Patents, like contracts, are artificial constructions 
between two parts: the inventor and the society, represented by the Administration. The 
contractual relationship between creator and society provides a series of terms on exclusivity 
rights over a certain technology, which are limited by the content of the claims.  
The benefits of the contract interpretation are essentially the easier possible interpretations to 
achieve over doubts and obscurities present in the reach of the claims’ protection—thus 
providing legal certainty. At this point, a different strategy is used when solving these 
                                                   
 
75 Such as VIDAL-QUADRAS. Besides, some court cases have considered the application of an interpretation of 
patents under contract law (i.e., Markman v Westview 517 U.S. 370, in the year 1996). At Vidal-Quadras, Estudio 
sobre los requisitos de patentabilidad, el alcance y la violación del derecho de patente, 152. 
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doubts in the interpretation of protection breadth present in the claims, analogous to 
contracts: the will of the parts.76 
In contractual interpretation, in case of doubt, the subjective element is called upon: it 
usually attempts at understanding which was the will of the parts at the moment of signing 
the contract. Further answers are obtained by an analysis of these wills. However, in the case 
of patent contracts, one of the parts (society) did not participate in the negotiation.77 In these 
cases, the principle of ‘doubts damage the person who originated them’78 applies; thus, any 
doubts may negatively affect the applicant, who should have pre-empted any obscurities in 
the contents of the claims.  
Indeed, this interpretation is rather negative for the applicant, who has to make a greater 
effort writing the claims, but it provides legal certainty to third parties beyond the terms of 
the mere interpretation of patents as legal texts. 
Evaluating the infringement 
Once the protection breadth conferred by a patent is determined, there will be a defined 
scale to judge possible infringements of the patent. A patent is not infringed if the activity 
concerned is not covered by the geographic, time and substantive protection of the patent. If 
a patent is actually infringed, the patent holder may claim to make the infringer to desist 
from infringing the patent—an injunction—, and/or claim for damages79 if criminal intent or 
negligence of the infringer is further established. 
Infraction judgment has nothing to do with the subjective issues of the case: it is irrelevant 
whether the offender of the patent has reached the same result by inventing it independently 
to the patent owner did not know the existence of the patent. Likewise, and in a slightly 
                                                   
 
76 Arts. 1282, 1284 and 1285 Spanish Civil Code. 
77 The elements of the patent-contract are determined by the applicant’s definition and their capacity to convince 
the examiner of the validity of the application. 
78 Art. 1288 Spanish Civil Code. 
79 To calculate the amount of these damages, patent holders have three options: the profit they have lost, the 
profit made by the infringer or the amount of money they would have received if they had granted a license. 
EPO, Patent Information, Brussels: EPO, 2008, §3 http://www.european-patent-office.org/wbt/pi-tour (accessed 
20 February, 2011). 
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different fashion to other IP rights, such as industrial designs or copyrights, inspiration is not 
considered an infraction of the patent: the realization must contain all the elements protected 
in a particular claim. 
When a specific third party realization of the invention includes at last all of the elements 
claimed, an infraction by identity has been committed, and its judgment is relatively 
evident.80 
Another source of lack of legal certainty on the judgment of patent infringement is the 
special characteristics of a realization of the invention. When one or more of the elements 
protected is substituted by some technical equivalent, a new question arises: was the 
equivalent element sufficiently pre-empted in the patent claims? More likely than not, an 
individual analysis of the elements composing the patent will be required, following by an 
analysis of the evidence of the substitution, in order to determine if the infraction by 
equivalency exists.81 
Enforcement and retaliation 
The importance of patents in economic terms is uncontested and, as pointed out before, can 
really hamper the aspirations of competitors. It is hardly conceivable that a company accused 
of unauthorized use of a patent would not try to defend itself by any possible means. One of 
these acts of retaliation in these cases is achieved by attacking directly the source of right, 
that is, by alleging that the patent should not have been granted in the first case.  
For similar reasons, valuable patents may likely be challenged after granting,82 or when a 
third party is affected by them, i.e., if a company owns a patent which is dependent on other 
patents and wishes to revoke them. 
These arguments of challenging validity of a patent or retaliation of infraction are logically 
opposed to the ones defending the position of the patent owner. Thus, the attacker or alleged 
                                                   
 
80 Vidal-Quadras, Estudio sobre los requisitos de patentabilidad, el alcance y la violación del derecho de patente, 239. 
81 Ibid., 242–245.  
82 Or during proceedings at the EPO, USPTO and JPO pre-granting opposition, which are treated in a different 
way. 
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infringer will likely contest that the infringement use does not fall under the reach of the 
exclusivity right, and attack the validity of the patent. This second accusation motivates a 
second legal process, forcing a threatening situation on both sides. 
Litigation on patent issues involves a substantial cost to all the parties involved,83 both as 
monetary costs of the proceedings and commercial losses derived from periods of fabrication 
uncertainty or injunctions. These reasons usually force the different parties to reach an 
agreement, which could be a solution beneficial to both parties. Or not, after all, settlement is 
more likely to represent the economic portfolio strength of the two parties rather than their 
actual legal position. In these cases, settlements could usually entail a licensing or cross-
licensing agreement.84 Or, more drastically, the acquisition of one of the contestants by the 
other. 
2 . 5  P A T E N T  O W N E R S H I P  
Patents, as intellectual property, are considered personal property, and could indeed be object 
of any case of juridical deals—selling, licensing or loans. In the IPRs, including patents, there 
is different consideration between the personal right to be acknowledged as the creator and 
the commercial right to exploit economically the fruits of the technologyare different things. 
All patent systems recognize the inventor as the original owner of the idea. The authors of an 
invention, likewise, must be named on the patent application. Thus, inventors are the owners 
of their inventions, although they may be obliged by contract to the cession of their idea—to 
their employers, usually. 
Most patent offices do not take the distinction between author of the invention and applicant 
of a patent further than recognizing authorship of the first. The applicant, who could be a 
company, will finally be the owner of the patent rights. In the US, on the contrary, only 
                                                   
 
83 Typical costs of patent litigation are in the range of €40,000 (Europe) to $3–4million (US). In EPO, Scenarios for 
the future (Munich: EPO, 2007), 40. 
84 Licensing and cross-licensing are common figures in the ICT industry, and are further discussed in section 
2.5.4. 
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inventors have the right to apply for a patent, and thus formal ownership of the patent, 
while their employers are considered assignees.85 
Ownership of patents is, indeed, a complicated matter. Complexity of new products 
patented and increasing of innovative processes in businesses intensify situations where 
collaborative innovation is needed, and where inventions are developed in the workplace. 
These situations present special cases of ownership of patent rights, which will be further 
discussed. 
2.5.1 Joint ownership 
In the case of inventions made collaboratively by several inventors, the ownership of the 
invention belongs to them all. Consequently, they could apply for a patent together, and 
become joint owners of the granted patent. Personal rights—authorship—are not 
transferable and, generally, non-joint invertorship can be extended to a third person that has 
not contributed to the invention. 
As a general rule, joint inventors need to designate a principal delegate for the realisation of 
typical bureaucratic actions at patent offices. Typically, any member of the joint patent could 
carry out beneficial or non-invasive actions towards the patent right. On the other hand, 
mutual agreement between all patent joint owners will be needed to execute other actions 
that are considered detrimental for the patent right.86 Patent office regulations and national 
joint-assets legislation of the different countries could provide further adjustments. 
2.5.2 Individual inventorship and ‘interference procedures’ 
On the other hand, inventions carried out by different people in an individual fashion, could 
only be protected by one—and only one—of these inventors. 
                                                   
 
85 Junghans, Class, Levy, Adam, Intellectual Property Management: A Guide for Scientists, Engineers, Financiers, and 
Managers (Weinheim: WILEY, 2006), 16. 
86 I.e., in Spain, art. 72 SPL and Common Law on Community Property regulate these interactions. These are 
typical actions that could be done by one of the joint applicants: selling of their part of the patent right (giving the 
opportunity to the other applicant to buy it first), exploit of the protected invention, paying patent renewal fees, 
and suing infringers of the patent. Conversely, these are actions that will need the agreement of all joint-
applicants to be executed: withdrawal of an application, and concession of a license to any third-party. 
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Both authorship and ownership of patents is differently solved in the US and the rest of the 
world. As a general rule, patent offices grant a patent right to an invention to the person who 
applied first it, that is, the patent application with a lesser ‘priority date’—so called first-to-
apply systems. 
In exchange, in the US patents are granted to the person who could prove to have had the 
idea before, and are therefore first-to-invent systems. It may be noted that, besides US 
inventors, this fact is particularly important for any other inventor or company interested in 
protection in the US. Even being the first person to apply for a patent would not prevent you 
from having to prove that you are the person who actually invented it first—which would 
certainly require research notes, sketches and other recorded proof. 
Disputed ownership in the US is contested by ‘interference procedures,’ which seek the 
determining of the actual date of invention.87 
2.5.3 Employee inventions 
The pace of advancement and complexity of technology88 provide a framework for 
innovation hard to achieve by individual inventors without proper equipment and research 
support. Due to these working constrictions, most economically-significant technological 
inventions are created by R&D workers in well established companies.  
The fact that inventions are made by employees of a company provides further conflict about 
who is the owner of an invention. Principles ruling such ownership should be found in the 
applicable law—in this case, industrial and IP legislation. According to the principle of 
inventorship, creations belong to their authors. However, industrial law states that labor 
belongs to the employer.89 In a sort of compromise, the different national laws provide that 
                                                   
 
87 In US legal practice (35 USC 135), the inventive act consists of two phases: the ‘mental’ idea of the operative 
invention and the actual ‘reduction’ to practice—the realisation into a physical form. The actual ‘inventor’ is 
always considered to be the proven first person to conceive the invention, but only if he or she can also 
demonstrate diligence towards the goal to reduce the invention to practice. 
88 Effects further discussed in section 4.1. 
89 Junghans, Levy, Intellectual Property Management, 74. 
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worker-inventors should be granted authorship—‘moral right’—and ownership of the 
invention, but the worker must normally transfer their rights to the employer.  
In some susceptible working areas for inventing, such as research departments, transferring 
of ownership of inventions is generally regulated by contract. In most other cases of 
employer inventions, an economic compensation is negotiated. 
In most jurisdictions, it is customary to differentiate differentiated between ‘tied’ and ‘free’90 
inventions. Tied inventions are related to work, made during the term of the employment—
even not during working hours—, and which are implicitly or explicitly included in the 
duties of the workers. Ownership of this type of inventions are granted to employers, who 
are provided a lapse of time to apply for a patent and make use of their rights; after that 
time, the rights of the invention are normally offered to the employee. Free inventions, on 
the other side, are those the worker creates outside of his or her working duties, with no 
relation to the industry of the employer or not applying knowledge from the company. This 
second type are normally own by the worker, who can keep all the inherent rights. 
It should be stated that there are quite significant differences in managing employee 
creation, depending on the country where the contractual relationship is established.91 
2.5.4 Transmission of rights 
As seen previously, personal rights of a patent—authorship—are not transferable; only 
rights with patrimonial nature are susceptible of being disposed to any third-party. In 
general, patent rights are transferrable by a licence, and can be sold, and handed over as 
goods or contribution to an enterprise.92 In the US, as well as in some European countries, 
patent could be also used as loan assets.  
 
                                                   
 
90 Using German legal practice nomenclature. 
91 In Germany, there are predefined royalties and the possibility to employees to patent in the countries not 
covered by employers’ patents. In Spain, on the contrary, even inventions made by the employee one year after 
contract extinction could be deemed as belonging to the prior employer.  
92 Individual claims of a patent are not susceptible to be transferred. 
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Licensing 
A patent right entails to its owners exclusivity over the use of the product or process 
protected, and allow them to profit of the monopolistic situation—provided they could bring 
their idea to the market. The level of investment required to market the invention and obtain 
a profit from it could be high, and probably would require further assets to commercialize 
the product globally. Financially, it is easily out of reach of individual inventors and SMEs. 
Licenses are mechanisms that provide the owner of a patent the purest form of income from 
his or her right: monetary income without having to sell the patent. 
The basic structure of a license agreement is as follows: the owner of the patent—the 
licensor—allows a third party—the licensee—to use his or her patent rights, normally for 
economic revenue. Formal rights are kept by the licensor, but the licensee is authorized to 
manufacture and market the invention; thus the licensee is excluded of the general 
prohibition of exploit.  
In most license agreements, at least a part of the revenues paid to the licensor are based on 
the licensee’s sales of the products covered by the patent. Such figure is called ‘royalties,’ and 
is referred to the number of units sold or the revenues from the selling—net sales—made by 
the licensee. 
Licensing agreements may be differently made. With regard to the scope of the license, it can 
be limited territorially, permitting the market of the invention in other countries, where the 
company lacks the assets to enter.93 Limits to the kind of utilization to a precise range of 
actions are also possible—licenses for research, diagnostics, manufacture of certain products, 
or only market. Finally, licenses can be granted ‘exclusively,’ that is, the licensor may not 
further grant any other license referring to the same scope to any other third-party. 
                                                   
 
93 ‘Worldwide’ licenses would have the effect to use the rights anywhere in the world. However, a licensee would 
rarely pay royalties for products sold in countries where there are no implemented methods of IP. 
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The importance of licensing and cross-licensing94 agreements is precisely the flexibility 
degree that can be achieved, and are extremely helpful at settling situations of intense 
litigation and technology-dense frameworks.95 
However, there exists a possible anti-competitive effect of certain license agreements, which 
could cause that some clauses be enforceable under competition law. Most countries have 
laws prohibiting agreements negatively affecting on competition, while considering the 
agreement void or subject to a certain fine.96 
Exhaustion of rights 
After marketing products protected by a patent, the exclusivity of right of the patent owner 
cannot impede future exploit of these products by the people who have acquired them. This 
figure is known by the name of exhaustion of rights, and is applicable in the country where 
its owner or an authorized third sold the product. The principle applied is that a product is 
marketable only if the purchaser may resell it.97 
This is particularly interesting in the case of licensing in the territory of the European Union, 
as exhaustion applies in all member states once the product is sold in one of them.98 
Expropriation and compulsory licensing 
There are different situations where patent owners could be deprived of their ownership of 
their rights over an invention, or their exclusive rights diminished to permit exploitation of 
their inventions without their consent. 
                                                   
 
94 Situation when two companies license parts of their patent portfolio to the other, so each of them becomes 
licensor and licensee at the same time; thus permitting access to a range of technology. 
95 As presented in section 4.2. 
96 Near-monopolistic situations are parts of the IP game, however, specific restrictions are considered in the 
European Union under article 81 of the ECT (European Community Treaty) and the TTBER (Technology Transfer 
Block Exemption Regulation). 
97 Art. 54.2 SPL 
98 I.e., in the case of licenses, the owner does not have any means to prevent the resell in Germany of its products 
sold by its licensee in Portugal. So, it is not possible to license more than one territorial license in the European 
Union. 
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Patent applications or already-granted patents could be expropriated by means of a public 
utility or social interest.99 The owner has the right of a full compensation, in any case. It 
could be the case of invention in which the country is interested in entering public domain.100 
In some countries, owners of a granted patent have a determined lapse of time when they—
or an authorized licensee—must exploit their invention to provide sufficient production to 
satisfy demand of the territory where the patent has been granted.101 In case of insufficient 
manufacture and patent dependence,102 the state would grant compulsory licenses to thirds 
requiring it, against the will of the patent owner if necessary. These compulsory licenses 
would be non-exclusive, and would provide economic revenue to the patent owner based on 
the importance, on economic terms, of the invention. 
2 . 6  A D M I N I S T R A T I V E  P A T E N T  P R O C E S S  
Process for patent concession, its formal and matter requirements and, occasionally, the 
reach of the rights granted, vary within the different national patent systems and 
international treaties— some examples were already presented in this chapter. However, the 
fundamental process for obtaining patent protection remains essentially similar in any given 
national, regional or international system. 
2.6.1 Fundamental procedure 
These are the three essential phases of application and granting of a patent in any given 
patent office: 
1. Application. The agent requiring protection for an invention may present a patent 
application to one of its designated patent offices. The date of the filing of the 
                                                   
 
99 I.e., art. 73 SPL. 
100 I.e., the French government bought the Daguerreotype patent in 1839 to provide it to the public domain. 
101 Spain is one of such countries, with compliance to produce between 4 years after applying, or 3 years after 
granting. Art.83 SPL. 
102 That is, patent A owners requiring another previous patent B to actually produce their dependent patent A, 
shall be given a reasonable license on the scope of patent B, if the invention establishes a technological 
advancement or is of economic significance. Art. 31.l TRIPS. 
V Í C T O R  M O R A  R O D R Í G U E Z   T E L E C O M  B C N  –  U P C  54 
application at the patent office is called the ‘priority date,’ and will be considered the 
same throughout the process and ulterior filings to other offices. The application 
should disclose the invention with such detail that a person skilled in the art could 
understand it entirely and make use of it. More interestingly, claims—aspects of the 
invention—are the part of the application where the solicitor declares explicitly the 
exclusivity rights he or she demands. Various fees may apply, and formal 
requirements must be fulfilled.103 
2. Examination. The patent office appoints an examiner, who is a person skilled in the 
matter of the invention claimed, to deal with the application. The examiner verifies the 
novelty of the invention, by means of determining that the invention is not part of the 
relevant state of the art—all disclosure in scientific and technical literature, published 
prior to the date of application. Afterwards, the examiner proceeds to determine if the 
invention implies inventive activity, or is non-obvious, in relation to the state of the art 
previously considered.104 The applicant may present an oral or written opinion about 
these conclusions, and modify the reach of the application claims, if necessary. In some 
offices, none of this examination process happens, being only necessary to register to 
be granted a patent. Patent applications are usually made public, together with the 
report of the state of the art, 18 months after the priority date, with some exceptions.105 
3. Granting. The patent is not granted if a reason is found to reject it—the invention is not 
patentable matter or it lacks novelty, inventive activity or industrial application. 
Otherwise, granted patents are published and enter into force for a maximum period of 
twenty years from priority date, provided the holder maintains the yearly fees. Patents 
could be contested by third-parties, based on defects of patentability of the invention; 
such opposition could be presented either before the same patent office—such as the 
                                                   
 
103 Further information about formal requirements is given in section 2.3.5. Claims and rights were discussed in 
section 2.4.1. 
104 Again, further discussion concerning subjective examination of inventions—novelty and inventiveness—can 
be found in section 2.3. 
105 In the US, patent applications fulfilling certain requirements could be kept in secret until their granting. See 
section 2.6.3. 
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EPO, or the appeal courts of the USPTO and JPO—or in the national courts, depending 
on the patent office. 
2.6.2 Alternative pathways 
Protection for an invention by a patent requires fulfillment of a certain administrative 
process. For obtaining a patent for an invention, the solicitor files an application at a patent 
office, where the patentability requirements will be verified for protection to be granted. 
Alternative ways exist for inventors to obtain these patent rights and, depending on the level 
of commitment, strategy and international scope, one or the others pathways of application 
should be selected. The different available application pathways are national, regional and 
international, which will be briefly presented. 
National way. When deciding to protect an invention, the first stop is usually the presentation 
of an application into a national patent office,106 whatever may be the international 
strategy—that is, if the applicant is willing to obtain protection in only that territory, or in 
more. The date when the first patent application for any given invention is presented in a 
patent office, anywhere in the world, is known as ‘priority date.’ In the national offices, the 
period between the presentation of an application and granting or denying of a patent right 
varies from one national office to another—from two to eight years. 
Regional way. Regional offices are an additional option for patent procedures if the solicitor is 
looking for protection in any number of countries of one of the regions with this type of 
system.107 It is a centralized way of applying for protection, which permits to reduce the 
processes in the national offices—and more interestingly, the fees one may incur.  
International way – PCT. The Paris Convention of 1883 was the first step towards a worldwide 
homogenization of the patenting processes. In 2011, 143 countries have ratified the treaty, 
thus permitting to any solicitor willing to apply for a patent in more than one of these 
                                                   
 
106 Usually the national office of the country of the solicitor, but there is no restriction in this respect. 
107 These are the regional patent offices existing at the time of writing: African Intellectual Property Organization 
(OAPI), African Regional Intellectual Property Organization (ARIPO), Benelux Office for Intellectual Property 
(BOIP), Eurasian Patent Organization (EAPO), European Patent Organization (EPO), Interstate Council on the 
Protection of Industrial Property (ICPIP), and the Patent Office of the Cooperation Council for the Arab States of 
the Gulf (GCCPO). 
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countries to do so in the 12 months from the priority date. By doing so, protection would be 
applied from the date of the first filing in every country affected. Alternatively, and similarly 
to the regional process, applicants could use the process established in the PCT, which has 
some potential benefits: unified process, reduction compared to national fees and elapsed 
time for market study. The PCT process will be presented in more detail in this chapter. 
It is important to note that any regional or international patent applications must ultimately 
have a national status,108 as they have to be validated by the national offices of every territory 
designed. As such, unique national characteristics—both the concession process and the 
post-granting activity—must be taken into account when looking for protection in other 
countries.  
2.6.3 National and regional process  
Over the years, different international treaties have been used to harmonize the assorted 
national patent application processes, and to provide a more efficient protection for 
inventors searching for protection in multiple countries. In this sense, the Paris Convention 
and the PCT have had a fundamental role in harmonizing the rules of these processes. 
In the 90s, the signing of the TRIPS, under the WTO, established minimum criteria for IP 
regulation in the WTO member states. These changes are further discussed in section 3.4.2, 
but it is worth noting now that TRIPS introduced the minimum duration of a patent of 20 
years109 and the cover of all technology fields by patents110—including pharmacological 
products.  
In spite of the trend towards convergence, each patent office has its own regulations, 
essentially at the level of patent subject examination and processes. These differences are the 
target of further harmonization in the case of the principal world patent offices—namely, 
                                                   
 
108 There is no such thing as an ‘international patent.’ On the other hand, there is a ‘European patent,’ but in any 
case it has to be accepted by national offices to be fully operational. 
109 Art. 33 TRIPS. 
110 Art. 27.1 TRIPS 
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‘the Trilateral Cooperation:’ USPTO, JPO and EPO.111 The more detailed processes are to be 
found in the EPO, being a regional patent office. 
EPO procedure 
For practical reasons, the process of granting of patents at the EPO will be presented and 
discussed. This patent system is sufficiently relevant, closer to national systems, and 
harmonized with the European national patent offices, to be worth consideration. 
The European Patents’ Granting Convention, mostly known as European Patent Convention 
(EPC), was signed in 1973 and entered into force in 1977. As a result of the EPC, the EPO was 
set up for granting patents based on a centralized examination process, and to create one 
uniform body of substantive patent law. By means of presenting a sole application for a 
European Patent in one of the three official languages, an inventor can obtain patent rights in 
every contracting state of the EPC, thereby reducing costs.  
The patents granted by the EPO, ‘European patents,’ have the same rights, and are subjected 
to the same conditions as the ones granted by national offices of the EPC’s member states. 
European patents, after granting, are therefore considered a ‘bundle’ of national patents, 
which nonetheless need to be validated by the national offices of the designated states.112 
Applications for a European Patent113 may be filed directly at the EPO in Munich114—or its 
branches at The Hague or Berlin—or at any of the national offices of the 32 member states.115 
The language of filing could be any of the official languages of the contracting states, but a 
                                                   
 
111 Forming the ‘Trilateral Cooperation’ since 1983. Recently, the Korean Patent Office (KPO) and Chinese Patent 
Office (SIPO) joined the group. 
112 An actual ‘European patent,’ which would be valid in all EU states from the moment of granting at the EPO, 
does not exist as such. Given the difficulties of achieving an agreement on the issue—the EPO is still not an UE 
institution—and the importance of the actual ‘European Patent’ (a “key objective,” in words of the European 
Commission), other proposals are trying to reduce these differences. In this sense there is the London Agreement, 
on costs of translations and languages, and the EPLA, on litigation costs. Cite from the European Commission, 
“Enhancing the patent system in Europe,” Communication from the Commission to the European Parliament and the 
Council, (Brussels: 2007), COM(2007) 165 final, 4. 
113 An example of the typical costs of a European Patent are presented in Annex F. 
114 EPO, Guide for applicants, C.III.104 
115 See Annex E. 
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translation in one of the official languages of the EPO—English, German and French—must 
be made available within 2 months of the filing of the application.116 The language in which 
this translation is provided will be the language of all proceedings. The date of filing of the 
application is considered the priority date for all purposes. 
A European patent application consists of “a request for the grant of a European patent, a 
description and drawings of the invention, one or more claims, and an abstract.”117 
Alternatively, one inventor may reclaim the priority right for a previously patent application 
in a state party of the Paris Convention, or from a Euro-PCT application.118 One way or 
another, the correct configuration and other formal requirements are checked at filing.119 
Thereafter, the preparation of the search report is done. The search report is drawn up “on 
the basis of the claims, with due regard on the description and any drawings,”120 and 
contains all documents available to the EPO at the time of preparing the report,121 which 
helps to determine whether the invention related is new and involves an inventive step.122 
Based on the search report, a preliminary opinion on patentability is provided.123 This first 
stage of the procedure is completed by the publication of the application and the search 
report, but not the preliminary opinion, 18 months from the date of filing or priority—
whichever is the earliest—; or before, if requested by the applicant. The publication opens a 
period of time in which the applicant indicates to which EPC member states the protection is 
sought. 
                                                   
 
116 EPO, Guide for applicants, C.I.42 
117 Art. 78 EPC. The contents of a typical patent application were further discussed in section 2.3.5. 
118 A Euro-PCT application is a typical PCT application—an international patent application presented in section 
2.6.4—whose national step is made by a European Patent. 
119 These formal requirements are further developed at EPO Rules 56–60 and in the EPO Guide for examination A-
II.5, A-III, A-V.2, C-VI.3.1, E-I, E-II. It is not in the scope of this work to provide such detail, but it worth noting 
that the applicant is usually required to amend within a period of two months any errors or omissions existing in 
the files presented. 
120 Art. 92 EPC 
121 It will be established afterwards whether the date of the documents is in conflict with the priority date, with 
more attention to prior patent applications. 
122 Incomplete searches based on lack of meaningful matter or unity are considered in Rules 63 and 64, 
respectively. 
123 Rule 62 EPC 
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The second stage starts with the substantive examination of the patentability of the 
invention, which is performed by a three-member technically qualified division,124 by 
request of the applicant within 6 months from publication of the application. If the 
application is deemed allowable, a grant will be proposed; if not, an exchange of 
communications between the examining division and the applicant will occur and, if 
necessary, amendments to the claims, description or drawings will be made.125 This 
procedure is, therefore, finished by a proposal to grant or refusal of the patent application. If 
granted, the applicant will be required to pay the fees and perform any remaining 
formalities.126 The specifications of the European patents granted are finally published in the 
European Patent Bulletin. 
Competitors or opponents to the applicant may make comments during the latter of these 
proceedings, between the publishing of the application and the final grant;127 as the EPC 
system provides this possibility. Any third parties may also oppose the grant of a European 
patent within 9 months from the final publication of the granted patent, and they have the 
right to be heard presenting the basis for their opposition before the EPO. Any party 
negatively affected by a decision in almost any procedure of the patent process, may present 
an appeal, which is to be heard by the Board of Appeal,128 within two months of the 
concerned decision.  
After granting and exhaustion of all possible procedures before the EPO, the granted 
European Patent is thereafter sent to the members’ national offices which were previously 
selected by the inventor—that will require further formalities, mostly fees and translations. 
Competence over the patent is therefore transferred to the designated national offices and 
legislation: any future objections to the patent validity or infringements will be prosecuted in 
the courts of the member state, using its national laws. 
                                                   
 
124 Art. 94 EPC 
125 Rule 71.1 EPC, which is the only moment in the EPO procedure which an applicant can modify the claims—
amend. 
126 Normally, provision of the translation of the claims in the two remaining official languages. 
127 Mostly by providing documentary evidence to show that a patent should not be granted. 
128 Art. 106 EPC. In cases concerned with particular points of law, an Enlarged Board of Appeal shall be referred 
to, Art. 112 EPC. 
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USPTO procedure 
The establishment of the USPTO followed the statement of the art. 1§8 of the American 
Constitution, to “promote the progress of science and the useful arts.” The Congress of the 
US issued laws related to the patent system of laws related to the patent system under title 
35 USC. 
With the advent of global trade, companies have reason to seek worldwide protection for 
their inventions. To do so, companies must generally obtain and enforce a patent in every 
country where protection is desired. For any company outside the US willing to procure and 
enforce patent rights in that country, a clear understanding of US patent law is vital. There 
are many differences between the European and US patent systems—some clear, some 
subtle—, including filing of patent applications, procedures after grant, and litigation of 
patents. 
These are some of these differences between US and the standard patent processes, being the 
latter already presented in section 2.6.1. 
First to invent. In the US, patents are granted to the first person who invents the product or 
process, and not the person who presents the first application—which is the rule on the rest 
of states. As such, third inventors could allegedly retain a patent presented by prior 
applicants. It is therefore worth remarking the usefulness of keeping inventor notes and 
records when applying for an international protection, including the US.129 
Grace period. As referred to in section 2.3.1, the US is one of the states that dispose a ‘grace 
period’ for the valuation of novelty of an invention. During the year before the presentation 
of the application, the inventor may publish any disclosure regarding the subsequent 
claimed invention, i.e., in media such as academic reviews. 
Legal duration of patents. Since 1995, year in which the TRIPS entered into force in the US, the 
legal duration of patent rights has been of 20 years from the priority date. Before that, it was 
17 years after concession. 
                                                   
 
129 Effect further discussed in section 2.5.2. 
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Renovation fees. In most patent systems, renovation fees are maintained in a yearly basis. Due 
to the prior legal duration of patents, discussed in the previous point, renovation fees in the 
USPTO are paid at the years 3, 5, 7 and 11½ from granting. 
No examination request. Contrary to the patentability examination on-demand issued by the 
EPO, in which the applicant has 6 months after receiving the search report to request 
examination, the USPTO automatically considers this application as made. This is 
problematic for inventors who, in the light of the search report, could easily figure out that 
their invention is obvious or not new. 
Publication of the application.Before 1995, applications were published only once the patent has 
been granted, or not published at all if requested to do so by the applicant. Currently, 
applications are published 18 months from the priority date, although there may be 
exceptions.130 
‘Duty of Disclosure, Candor and Good Faith.’131 When presenting a patent application, solicitors 
are compelled to include a list of documents that, in their opinion and knowledge, could be 
relevant to the effects of determining novelty or non-obviousness of the patent. It is indeed a 
legal requirement, and not providing the data required could entail nullity of the patent 
application. In a quite evident consequence, applicants were including a vast number of 
documents into the compulsory ‘state of the art,’ hence forcing the USPTO to change the 
maximum number of references to 25, in the year 2005.  
Provisional patent application.132 The USPTO offers the possibility of presenting a provisional 
patent application, thus permitting a first application and priority date at a lesser cost—
because no patentability exam is done. Claims and disclosure are not required to be fully 
written, but further changes should be realized on the application to permit continuation 
towards the granting process. 
                                                   
 
130 35 USC 122b.2.B.i . There is a possibility of presenting a petition of non-disclosure, provided the applicant is 
not going to present an application in another country claiming the priority date of the US application concerned.  
131 35 USC 301 
132 35 USC 101b 
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Claims’ amendment.133 Solicitors may amend the claims of their application after the initial 
filing, to an extent substantially broader than what is permitted at the European offices. 
These changes could be done after new progress on the applicant’s research, or as a reaction 
to examiners’ requests. Thus, concession could be gradually delayed. This process could 
even begin two years after granting of the patent, in case of any deficiencies in scope of the 
written claims. 
Both the procedure of patent granting at the EPO and the USPTO are displayed in Annex C. 
2.6.4 International process – The PCT 
The Patent Cooperation Treaty (PCT) is a multilateral treaty that came into force in 1978,134 
administered by WIPO. The member states of the PCT135 establish a Union for cooperation in 
the presentation, searching and examining of patent applications. 
The scope of PCT is to increase easiness to processing applications for patent protection, 
when such protection is to be obtained in a various states. It establishes a system in which 
the filing of a single application produces the same effects as if the application would have 
been filed in each of the countries designated by the solicitor. 
The PCT is not a process of patent granting, and therefore does not substitute the national 
concession; it is a system for unification of previous processing of granting. So, by this means 
an international application does not result in an actual ‘international patent.’ 
A brief presentation of the PCT procedure follows for illustrative purposes; a graphical 
representation of the procedure could be consulted in Annex D. 
  
                                                   
 
133 35 USC 201 
134 The PCT was signed in 1970, and entered into force in 1978. In May, 2011; 143 state members formed the PCT. 
135 See Annex E. 
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The PCT procedure 
In accordance with the PCT, it is possible for solicitors to file international patent 
applications. An international patent application results in further possibility of obtaining 
patent rights for an invention in different countries.  
By means of a PCT application, the solicitor can delay the decision to apply for national and 
regional levels as far as 30 months from the application—as opposed to the 12-month period 
of the Paris Convention. Payments of fees and translations corresponding to national filings 
could be done relatively later on, thus benefiting the applicant with more information of the 
market value of the patent before confronting higher costs. 
The PCT process consists of two fundamental phases: 
1. the international phase, which is performed at the designated national (or regional) 
offices, the International Office (WIPO), and the Administration committed to the 
international search and the international preliminary exam; and 
2. the national phase, which takes place in the national offices of the designated states. 
The international phase starts with the filing of the international application, directly in a 
national (or regional) patent office of a PCT member—up to 12 months from the priority date 
of a previous patent national filing—, or directly at the WIPO.  
After reception, the patent application is transferred to one of the International Search 
Authorities (ISAs)—which are national offices specially designated by the WIPO to carry out 
the search process. The ISA prepares the International Search Report (ISR),136 which is 
essentially a report analogous to the ones prepared by national offices: references to 
documentation, both patent and not-patent literature, affecting to the invention patentability. 
ISRs are accompanied by a written opinion on whether the invention seems to comply with 
the patentability requirement, this said opinion being non-binding. The ISR is published 
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with their corresponding applications 18 months after the priority date137—the written 
opinions are not published. 
After receiving the ISR and the written opinion, and before the 22nd month from the priority 
date, the applicant may demand an International Preliminary Exam (IPE), which will entail a 
preliminary report of the patentability—a second evaluation about the potential patentability 
of the invention. If the applicant does not ask for the ISR, the written opinion will be the final 
ISR.138 
After that point, and the 30-month period after the priority date reached, the national phase 
starts. The applicants may apply for a patent in every country selected to effectively protect 
their inventions. At this point, it is also possible that, instead of filing a national application, 
the applicant may file a regional application,139 which would be solved afterwards. 
As it has been previously discussed, the PCT application must end in several national 
applications to achieve effective protection. 
Henceforth 
To summarize, after selecting the countries in which protection is sought, the options for the 
applicant are:  
a. to apply to the national office of each country separately and follow their procedures;  
b. to group some national applications at regional offices, such as the EPO; and  
c. to apply via the PCT for some or all of the countries and then proceed to a combination 
of regional and/or national offices, the regional offices leading automatically to 
national offices. 
In spite of the different possibilities, international companies demand further harmonization 
of the patent system. Practical and economic barriers arise when businesses need to apply at 
                                                   
 
137 Art. 21.2a PCT 
138 Art. 34.3c PCT 
139 I.e., in the case of the EPO, the Euro-PCT. 
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different patent offices, when seeking global protection for inventions. Indeed, the principal 
world patent offices—USPTO, EPO and JPO—do not have a standardized register 
mechanism, meaning further costs to these companies. 
Likewise, some patent offices are according cooperation towards a sole patent system.140 In 
any case, a single global international patent system is far from being a reality, as LDCs are 
quite aware of what a powerful tool it could be for MNCs. 
On the contrary, regional patent offices are being created, notably following the increasing of 
regional free-trade and commercial agreements. Patent system harmonization is a corollary 
of economic interdependence, stronger in regional blocks.141 
 
 
                                                   
 
140 Work-sharing pilots between patent offices, as the ‘Patent Examination Highway’ and ‘Patent Prosecution 
Highway’ between Japan, China and South Korea, which provides a rationalized application and prosecution. 
SIPO, SIPO and JPO to Commence a Pre-Pilot of Patent Prosecution Highway between Both Offices, 2009, 
http://english.sipo.gov.cn/news/official/201105/t20110511_603901.html (accessed May 19, 2011).And similar 
USPTO and IP Australia cooperation on patent search and end examination. USPTO, United States and Australia to 
Extend Cooperation on Patent Search and Examination Services, 2007, 
http://www.uspto.gov/main/homepagenews/bak2007feb07.htm (accessed May 19, 2011). 
141 ACC1Ó, Informe anual OME 2008: Un món policèntric: la cursa pel talent, la tecnologia i el capital: Crisis i 
transformacions en l’economia global (Barcelona: COPCA, 2008), 126. 
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3  T H E  B I G  P I C T U R E  –   
S O C I A L  &  E C O N O M I C  I S S U E S  
In this chapter, the patent system is portrayed as a conceptual ‘balanced model’ between the 
interests of innovative agents and society. The most challenging issues concerning this ideal 
model are outlined—either inherent to the patent system or external to it. In this sense, the 
patent system economic framework, as well as its relations to both global and business levels 
will be presented. 
What follows is a brief description of the justification of the patent system over the years, 
from its origins to the present. The Principles of the patent system itself will be discussed 
next. 
3 . 1  H I S T O R Y  A N D  E V O L U T I O N  O F  T H E  P A T E N T  S Y S T E M  
The first approach to a system of protection of inventions is the Edict of Venice, a Venetian 
law of 1474, where inventors were awarded with an exclusive right of 10 years if the 
invention was found useful. Before that, inventions were typically kept in secret. The 
primary role for patents142 was the transfer of industrial knowledge from inventors and 
foreigners for the nations’ benefit. The idea of public disclosure of an invention, in return for 
an exclusive right, spread through Europe in the following centuries and, eventually, to the 
new world. 
The concept of inventions’ exclusivity protection was followed by the Tudor English Statute 
of Monopolies, under King James I in 1623. This law provided for the first time for the grant of 
a monopoly for an invention during a limited length of time. During the centuries XV to 
XVIII, patent systems were better understood as ‘privileges,’ that is, inventions became state 
property, with private and exclusive right of use to inventors. The patent system at that time 
was the expression of the power of the state, arbitrary in its forms. 
                                                   
 
142 The etymology of the term patent comes from the Latin literae patentes, or ‘open letter.’ The term letters patent 
historically refers to sealed letters read as royal proclamations in thirteenth-century England.  
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The privileges granted by patent systems were calculated in terms of benefit given to society. 
And this principle was long recognized: to a point that it was a fundamental part of the 
American Constitution of 1787.143 Trade and industry flourished in the second half of the 
eighteenth century in many countries—as well as scientific advancement, artistic creativity 
and political revolution. In France, the first patent law was established in 1791, after the 
French Revolution. 
In the modern world of the nineteenth century, the patent system’s principal characteristic 
was the liberal background, and the granting of rights in a regular and legal basis, without 
the arbitrary nature of past systems. It is in the second half of that century, when patent laws 
had been already enacted in several countries and goods and workers started crossing 
national borders, that the need for off-territorial protection arose. Following an incident 
related to this lack of international protection,144 the first major treaty in IP protection was 
established. The Paris Convention for the Protection of Industrial Property was signed in 
1883, allowing inventors of one territory to obtain protection for their intellectual creations in 
other countries—patents, marks and industrial designs. Patents became the backbone of the 
industrialization process, and companies were established on the basis of a single patent. 
The evolution towards international harmonization of the patent regime further developed 
in the twentieth century. In 1970, under the recently-created WIPO, the settlement of the PCT 
defined a common process for filings and initial stages of patent applications in the different 
territories. In the 1980s, further attempts at harmonizing the IP law were attempted within 
WIPO, before shifting the diplomatic scene to GATT. The results of the negotiations 
culminated into TRIPS, which entered into force in 1995.145 At the same pace, there has been 
an evolution towards regionalism of the patent system, seeking common economic interests 
and gaining negotiation power. 
                                                   
 
143 Included in art. 1§8 of the US Constitution. The principle behind patent systems also boosted the creation of 
the US Patent Commission in 1790, ‘created to promote the Progress of Science and Useful Arts.’ 
144 Foreign exhibitors refused to attend the International Exhibition of Inventions in Vienna in 1873 because they 
were afraid their ideas would be stolen and exploited commercially in other countries. In WIPO, Summer School on 
Intellectual Property, 13. 
145 The TRIPS agreement is discussed in following section 3.4.2. 
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Overall, philosophy and justification of the patent system has changed radically during its 
history: from being justified in the ‘natural law’ and used mostly by individual inventors, to 
mainly having economic meaning nowadays and used by corporations to control global 
commerce. 
3 . 2  P R I N C I P L E S  O F  T H E  P A T E N T  S Y S T E M  –   
B A L A N C E D  M O D E L  
The declared objective of the patent system is to promote innovation, and therefore technical 
progress. It is achieved by a system of balanced compensation: a temporal right for exclusive 
commercialization of the invention, in exchanged for public disclosure of the idea. By means 
of offering useful protection and exclusivity, individuals are encouraged to invest time and 
money innovating on practical inventions, for the benefit of all society.146 The patent is a 
balanced contractual relationship between the inventor and the wider society, depicted in 
Figure 1. 
The ‘balance’ of the system is at the heart of the patent granting process, and is an 
appropriate model for the benefits (knowledge) and disadvantages (monopoly) in which the 
system incurs. On one hand, the possibility of obtaining a patent right is an incentive to 
innovate147 for the overall benefit of society. With a limited monopoly, patent owners are 
allowed to sell the technology above the market price, or transfer it to others, converting 
patents on negotiation tools, recouping the costs of research of the invention, thus permitting 
even future innovations, and eventually enabling the movement of resources in the market. 
                                                   
 
146 According to art. 7 TRIPS, “[t]he protection and enforcement of intellectual property rights should contribute 
to the promotion of technological innovation and to the transfer and dissemination of technology, to the mutual 
advantage of producers and users of technological knowledge and in a manner conductive to social and economic 
welfare, and to balance of rights and obligations.” 
147 The correlation between patents, innovation and economic growth has a hegemonic view in institutional 
sources, and is implied during the study. However, it is still an issue where the academic opinion is divided. 
SCOTCHMER, GUELLEC and VAN POTTELSBERGHE hold the point of view of patent systems increasing 
innovation. MANSFIELD disagrees with the proposed model. Guellec, D., van Pottelsberghe, B., The Economics of 
the European Patent System (Oxford: Oxford University Press, 2007); Scotchmer, Suzanne, Innovation and Incentives, 
(Cambridge: MIT Press, 2004); Mansfield, Edwin, Intellectual Property, Technology and Economic Growth (1990). 
Empirical proving concerning patents and innovation can be found in Hu, Albert, et al., Patent Rights and Economic 
Growth: Evidence from Cross-Country Panels of Manufacturing Industries(2009). 
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This exclusive exploitation of their invention is barely achievable by means of maintaining 
the invention secret. Also, by allowing disclosure of the invention, future efforts of R&D are 
focused on novel areas, avoiding duplicated research efforts. 
 
 
Figure 1 – The patent system model 
(the same model, with its flaws depicted, can be found in Annex A) 
Source: EPO, Scenarios for the Future 
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On the other hand, granted patents also have some ex post costs to society. By means of 
granting a legal monopoly to a patent applicant, the competency in the market is limited, 
with the products patented offered at higher prices.148 Incentives given to innovators have to 
be balanced with the public interest of consumers, so that the access to the products is not 
excessively hampered;149 but these incentives also have to be balanced with the rights of 
competing businesses, so that they can enjoy innovation and development on their own. 
Patent rights limit production competence, but promote competence in innovation.150 And, 
not to forget, patent systems also incur in some elevated costs, both to the inventors (patent 
applications and fees) and to its internal administration. 
3 . 3  C H A L L E N G E S  F O R  T H E  P A T E N T  S Y S T E M  –   
U N B A L A N C E D  M O D E L  
The theoretical base of the ‘balanced’ patent system already presented is not free of criticism, 
with respect to its overall beneficial character. Although historically there have been 
episodes of skeptical views over the patent system,151 it is in the final decades of the last 
century that actual discontent voices began to be heard and become a wider trend than ever. 
The patent debate is centered over different issues: those intrinsic to the patent system and 
those extrinsic to it—affecting markets, economic development, and technological 
innovation. The extrinsic effects of the patent system will be addressed in the following 
chapters; the inherent issues will be discussed in this section. 
 
                                                   
 
148 This could affect the market in different ways, but essentially, some consumers are excluded from acquiring 
the product (willing to pay the marginal cost of the product, they are not willing to pay the surcharge to the 
patent holder). Others consumers would use substitutive products with lower prices, even if they require more 
resources to manufacture. 
149 Which is more important in the case of LDCs, with an already hampered access. 
150 Llebot Majó, Josep-Oriol, La propietat industrial (I): El sistema de patents (Barcelona: Fundació UOC, n.d.), 10. 
151 And even more drastic measures: the abolition of the patent system in the Netherlands in 1869, not 
reestablished until 1912. Macleod, Christine, The Patent Controversy in the XIXth Century (Bristol: University of 
Bristol, 2005). 
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Protection of new fields of technology and ethical issues 
From the industrial-based knowledge protected by patents during the nineteenth century, 
society is moving towards other goals. New technical fields, for instance biotechnology, have 
incremented their relevance during the second half of the twentieth century. This technology 
has become patentable in some countries over the years,152 including examples extremely 
controversial. Several landmark patents over ‘life’ have caused broader debate on the ethical 
issues concerning patent systems,153 with attention to patents related to embryonic stem 
cells.154 In these cases, social fears over the nature and risks of technological research are at 
the focus of the discussion—not exactly patent systems’ position.  
Moreover, ethical matters governing patents are today concerned to issues related to least-
developed countries (LDCs). Monopolies granted in fields such as agricultural and medical 
technologies encourage civil society debate on the undesired social and economic effects of 
the patent system—primarily, limited access to corporative patented goods, such as AIDS 
drugs and essential food crops. But these issues reveal different political outlooks more than 
conflicting interests. 
Quality of granted patents – High number of applications 
At the core of the patent system, ‘quality’ measures a patent’s degree of validity and it 
maintains the desired balance between incentives to inventors and third-parties rights. 
Indeed, low-quality patents produce all the inconvenient effects of a monopoly while 
reducing the benefits for the public. Patent offices, by means of the procedures of search and 
examination,155 ensure the balance between the reward to the inventor and interest of 
society, and thus they maintain a level of validity by discarding patent applications that are 
considered ‘obvious.’ Substantive examination carried by the offices aims at achieving 
                                                   
 
152 Patentability criteria vary in the different national and regional patent systems. 
153 I.e., the Edinburgh Patent case (European Patent No.0695351) in 1980, on animal embryonic stem cells; and the 
different Oncomouse Patents in the 80–90s. 
154 It is arguable that the use of embryonic stem cells is sufficiently pre-empted by the excluding of patent matter 
“contrary to ‘order public’ or morality.” Art. 53.a EPC. 
155 The patent application process and patent offices’ work was presented in section 2.6. 
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quality but, more often than not, examination is constraint by both time and assessment 
limitations, caused by the overall patenting proliferation.  
The increasing number of applications is an evidence of the importance and success of the 
patent system. However, the growing number of these patent applications has led to 
important blockages of the patent granting system. Patent offices face a high volume of 
applications, which create backlogs156 that could lead to increase the rate of work at the 
offices. If asked to increase their pace of work, examiners could not have sufficient time to 
procure an adequate substantive search, and therefore they could misjudge obviousness, 
upset quality and cause increasing uncertainty in the granted patents.157 
Low quality patents have higher costs to society, not only because of increased prices of 
exclusive products, but also because of the expenses incurred in more litigation processes.158 
Also, there is less social interest in low-quality patents, and more and more concerns about 
the level of quality of granted patents159—patent systems are there for rewarding genuine 
innovation. 
 
                                                   
 
156 A recent study by the British Patent Office states that the size of the global patents backlog is over 4 million 
unprocessed applications. The same study shows that the estimated losses on economic activity because of 
pendency delay is 7.6 billion pounds for year of delay in Europe, US and Japan (as a complementary note, 
average grant pendency is 3–4 years). London Economics, Economic Study on Patent Backlogs and a System of Mutual 
Recognition (London: UK Intellectual Patent Office, 2010), 44. 
157 Ibid., and Jaffe, Adam, Lerner, Josh, Innovation and its discontents (Princeton: Princeton University Press, 2004), 
20. 
158 Since patents deemed weak are predictably more challenged by its competitors. 
159 In the US, the problem of trivial patents is usually linked to a diminishing of the patent standards. Patent 
approval rates are higher in the US than in Europe and Japan. At the USPTO 99% of patent applications are 
approved, contrary to roughly 65% in the EPO and JPO. The small quantity of examiners per application (34,000 
examiners for 350,000 applications a year in the US, with a time of 11 to 22 hours per patent) is considered not 
enough. USPTO, as other offices, is financially based on patent fees (which are paid only if the patent is granted), 
so it is accused of having the incentive to process applications quickly rather than diligently, and with higher 
approval rate. Jaffe, Lerner, Innovation and its discontents, 4–6. 
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3 . 4  E C O N O M I C  G L O B A L  R O L E  O F  P A T E N T S  
The patent system—and, in a broader view, all IPR management and protection—is, and has 
always been, a matter of states, of protection within their borders. However, on the last 
quarter of the century non-state actors, such as MNCs and international NGO, have played 
an increasing role, and the same can be said of supra-national actors, such as WIPO and 
WTO, and regional institutions.  
3.4.1 Governance, globalization and development 
The roots for the gradual switch from traditional state governance towards international 
political powers can be found in economic liberalization and globalization. From the 
traditional situation of centralized power of the nation-state, the situation has quickly moved 
to an increasing decentralization of political decision-making and witnessed a drastically 
reduced role of the state institutions. The result has been more economical freedom for 
organizations and individuals. The political power of the state has decimated, and new 
sources of authority have appeared, with relations trespassing traditional territorial 
boundaries. This territorial openness towards international trade and investment has made 
globalization possible—the cultural, social and technical interaction between countries—and 
has leveled up inter-state authorities globally.  
Companies are also turning to international expansion and foreign investment, interested in 
moving to regions with lower labor costs. In the ICT field, particular global service sectors, 
with virtually no physical barriers, can just be anywhere in the world. Globalization is 
indeed proving beneficial to some, but its benefits are not so evenly distributed between all 
countries. This unbalanced scenario has caused the rise in the latter years of a number of 
social dissenting groups that oppose global trade and its economic policies. Also, emerging 
countries are reticent about the neutrality and legitimacy of the geopolitical system. The 
governance of the global trade system is questioned. 
In this sense, current shifts in IP-related trade issues, which will be further discussed in this 
section, are marking the agenda of players at all levels: nations, and regional and 
international bodies. Although a ‘global’ patent system has been around for some time—
from the Paris Convention of 1873—, patent systems are managed basically on a territorial 
basis, with overall governance by regional and supra-national institutions, such as WIPO.  
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These three levels—national, global, regional—coexist, always negotiating and competing. 
Whereas at a national and regional level institutions focus on concerns over country 
innovation and competitiveness, at a global level, the collision between Northern v Southern 
states over development issues concerning patents marks the agenda. Moreover, emerging 
countries are now questioning the role IP plays in development, as well as the fact that it is 
under control of the rich countries. Indeed, technology transfer is central to economic growth 
and development,160 no wonder, then, that critical voices argue against the fact that 
industrialized countries are seeking commercial interests by means of patent system 
regulation, under the former blessing of WIPO.161 
Patents and IP have played a crucial role in the geopolitics of globalization and in 
technological development and technological for many years. The economic development of 
many countries is what is now at stake. 
3.4.2 IP and trade – The TRIPS agreement 
MNCs, companies operating at a global level, have always been eager to reduce differences 
in the regulations concerning patent systems, as they are source of increased patenting costs 
and legal uncertainty. In the 1980s, industrialized countries and markets pushed WIPO 
towards global IP law harmonization, which would have meant stronger protection of 
patents rights for its members. Developing countries refused at that moment the 
introduction of these higher global forms of protection.  
Lack of results during that period switched the negotiation field from WIPO to the 
Uruguay’s trade round of GATT (General Agreement on Tariffs and Trade) on 1986. 
Profiting from the expanded competences of GATT, which also included agriculture—an 
important aspect of global trade for developing countries—, IP started to be connected to 
trade. This was the capital step towards enforceable results: the Uruguay’s round of GATT 
                                                   
 
160 “The ability of countries to acquire, master, adapt and improve upon scientific and technical knowledge is a 
major determinant of their capacity to achieve sustainable economic growth.” In United Nations Commission on 
Science and Technology for Development, Issues Paper on ‘Bridging the technology gap’ (UNCTAD, 2005), 5. 
161 However, WIPO position has shifted, and today the organization is more concerned about development issues, 
contrary to WTO. This is especially manifest with the proposal for a Development Agenda for WIPO presented in 
2004. International Chamber of Commerce, Current and emerging intellectual property issues for business: A roadmap 
for business and policy makers (Paris: ICC, 2008), 21. 
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concluded with the negotiation of TRIPS, and the creation of the WTO, which would 
administer the new treaty, among others things. 
IP regulation finally shifted towards trade regulation when TRIPS was enforced in 1995. 
Whereas IP policies are concentrated in WIPO, WTO’s TRIPS has increasingly been taking 
political decisions—a move that has raised controversy, mainly because some of the 
principles originated for trade in goods, if applied to the non-trade context of IP, may not be 
suitable for all countries.162 
With the approval of TRIPS, patents were linked to the international trading system and, 
more importantly, to its sanctions mechanism.163 TRIPS signing require country members to 
adopt their IP protection systems to satisfy minimums requirements and precise rules for 
enforcement of IPRs. Its principal features concerning national patent systems are as follows: 
• Harmonization of patent rights is established (Art. 28).  
• Also, minimum levels for time protection of patents are implemented, determining 
them for 20 years (Art. 33). 
• Patents must be granted in all fields of technology, with several exceptions164 (Arts. 
27.2 and 27.3). 
• Not allowance of discrimination “as to the place of invention” in national patent laws 
(Art. 27.1). 
• Enforcement procedures should be made available in every state member (Art. 41). 
• No benefits for local applicants may be offered, if they are not available to other TRIPS 
members. (Art. 3) Most-favored-nation treatment is also included (Art. 4). 
It should be stressed that failure to comply with TRIPS can result in trade sanctions.165 
                                                   
 
162 Opinion of Martin Khor at EPO, Interviews for the Future (Munich: EPO, 2006), 492. 
163 ICC, Current and emerging intellectual property issues for business, 20. 
164 Not including software and business models, which are permitted. 
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The TRIPS agreement—exhibiting a pro-Western bias—does not reflect the contemporary 
concerns about health and development. Contrary to the purpose of the Paris Convention, 
which enabled countries to determine some aspects of the patent system in their national 
legislations, TRIPS denies that flexibility to developing countries.166 Eager use of the IP 
system in the last century at the service of developing objectives proved successful to some 
of them.167 The ‘copycat’ effect is still a very important resource for early economies. 
The lack of technology transfer, and the IP constraints on LDCs included in TRIPS lessen the 
ability of technology exploit and innovation.168 Likewise, debate increased and Article 66.2 of 
TRIPS was formalized, which encouraged technology transfer to LDCs from foreign 
enterprises.169 According to analysis, the provision has received little attention.170 
The concerns of LDCs with TRIPS, led to the Doha Declaration on the TRIPS Agreement, in 
2001,171 which included flexible provisions concerning public health. These measures include 
the use of patented drugs in emergencies related to epidemics (as AIDS or tuberculosis) by 
any possible means;172 and the possibility to delaying the introduction of drug patents into 
national legislations until 2016. In the same sense, it has also been proposed a WIPO 
Development Agenda,173 with a focus on development aspects of IP, mainly technology 
transfer and delivery of technical assistance. 
                                                                                                                                                               
 
165 Reidenberg, Joel R., “Trade, TRIPS and TAFTA,” Fordham Intellectual Property, Media and Entertainment Law 
Journal4, Issue 1, Article 17 (The Berkeley Electronic Press, 1993). 
166 EPO, Scenarios for the future, 59. 
167 I.e., South Korea and Taiwan, which refused most part of foreign patents during their economic take off (late 
60s), in part because their local industry was founded on imitation. Latrive, Florent, “Propriété intellectuelle: les 
pays du Sud se rebellent,” Libération, September 20, 2004. 
168 As scientific programs improve human capabilities, and technology boosts productivity and increases 
economic growth. 
169 Art. 66.2 TRIPS “Developed country Members shall provide incentives to enterprises and institutions in their 
territories for the purpose of promoting and encouraging technology transfer to least-developed country 
Members in order to enable them to create a sound and viable technological base.” 
170 United Nations Commission on Science and Technology for Development, Issues Paper on ‘Bridging the 
technology gap’ (UNCTAD, 2005), 11. 
171 At the time of writing (May 2011), the Doha round is still not concluded. 
172 Measures including compulsory licensing and ‘grey imports.’ 
173 Leaded by Argentina and Brazil, in 2004. 
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On the other hand, given the slow progress renegotiating TRIPS,174 most developed 
countries (notably the US) chose to increase pace of this economic agreements relating to 
IPRs. Some bilateral and FTAs include now the so-called ‘TRIPS-plus’ clauses, which impose 
higher standards, extensions to patent rights and more limited exceptions to LDCs as the 
original TRIPS itself.175 The limitation of the use of compulsory licenses and the increment of 
exclusivity rights is a sensitive loss with regard to the Doha Declaration. Reports176 insist in 
the fact that the stricter TRIPS-plus clauses are contrary to development: stronger patent 
regimes encourage MNCs to stop production and investments in the country.  
3.4.3 The power shift eastwards 
IPRs are an important component of current trade agreements. The presence of WTO and the 
TRIPS agreement integrate an almost universal framework, defined by the northern-western 
block. The increasing balance of geopolitical powers around the globe is bringing other 
countries to the patent system, interested in exploiting it, thus breaking the traditional 
domination of patent superpowers—US, Europe, Japan.177 
Industrial manufacture has already been moved to the south and east, and now is R&D that 
is shifted to these countries—notably China and India—, because of lower workforce costs 
and shorter distance to emerging market forces. As an effect to this shift of research, “this 
will lead to a clear knowledge transfer towards China, irrespective of who the owner of the 
IP is.”178 
Technology transfer accelerates development, and emerging countries are eager to make use 
of IP systems. International protection of innovation is really precious as a national 
                                                   
 
174 See note 171. 
175 Examples of FTAs including clauses considered TRIPS-plus can be found at The World Bank, Global Economic 
Prospects: Trade, Regionalism, and Development (Washington: The World Bank Publications, 2005), 66. 
176 Ibid., 98. 
177 Which in fact defined the contemporary IP regimes. “The forces that pushed for the harmonisation of laws that 
resulted in the TRIPS Agreement are very well known. They are the big industries, the drug industry, the motion 
picture industry, those industries that wanted to have a higher standard of intellectual property in countries 
outside the US and the EU.” Martin Khor at EPO, Interviews for the Future, 480. 
178 Joseph Straus, at EPO, Interviews for the Future, 286. 
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competitive advantage and to dynamic technological fields.179 The new geopolitical and 
technological muscle of emerging countries can disrupt the current global patent dominance 
of existing superpowers. 
3.4.4 Patent systems: North v South 
Developing nations do the R&D, the manufacture, yet still they don’t see the revenues of the 
developmental advantage of IP. Traditionally, technical information was received in 
exchange for local protection, and goods and wealth were produced. Developing states see, 
on the contrary, an increase of the international licensing revenues to developed countries.  
Most developing countries lack an IP strategy linked to development. These countries have 
to develop a strategy appropriate to their level of development, and analyze carefully IPR 
provisions in the RTAs, but it is not always an easy situation.180 
The orthodox approach is: the higher the IP standards, the more innovation and technical 
growth, and therefore, progress. But on certain levels of development, this approach may not 
be true.181 Developing countries, with little economic flexibility, have more to gain from 
shorter patent terms for foreign innovations, since that facilitates the spread of new 
technology and the diffusion of ideas.182 
The TRIPS agreement does not address certain issues concerning LDCs and their integration 
to a global patent regime, such as the effects of IPRs at certain economic levels, the 
overwhelming of national patent systems by foreigners, and the monopolies and higher 
prices, not affordable by poorer consumers. 
In my opinion, the effect of strong patent rights in developed countries, with business and 
individuals strongly formed in IP, is surely beneficial for improving innovation and 
economic gain. On LDCs, however, strong patent protection is a backdoor opened for 
foreign capital to exploit them. 
                                                   
 
179 OEPM, Plan PI: Plan de promoción de la Propiedad Industrial en España 2010-2012 (OEPM, 2009), 8. 
180 The World Bank, Global Economic Prospects, 72. 
181 Martin Khor, at EPO, Interviews for the Future, 492. 
182 Surowiecki, James, “Exporting I.P.,” The New Yorker, May 14, 2007.  
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3 . 5  B U S I N E S S  –  P A T E N T S  A S  S T R A T E G I C  T O O L S  
Current market economy is more and more based on a knowledge paradigm. This fact is 
increasingly changing market priorities. Businesses are largely relying in patent rights and 
other IPR—intangible assets—not only for its functionality to maintain monopolies, but also 
as financial assets. Indeed, patents are beginning to generate profits and strategic advantages 
for companies; so much so that physical assets are losing importance in the overall value.183 
In today’s interconnected world, businesses are becoming borderless and consumers are less 
and less concerned about the origin of the technological products they use. Companies are 
outsourcing their production and research, allowing other companies to take over part of the 
value chain. They generate revenues with their products, even if they are actually not 
making anything—patents are changing their value. In this intensely globalized system of 
patent protection, businesses argue for predictability.  
Too much economic value is at stake and companies are quite aware of this. Beyond the legal 
procedures and technical nature of patents, there is a business strategy that drives patenting 
interests—the pursuit of a patent portfolio requires the consumption of both human and 
financial resources. 
Businesses are therefore increasingly seeking protection based on patent rights, either from 
internal innovation or by acquiring third-party patents. The business motivations behind this 
patenting boom that has evolved over the last 30 years are numerous: commercial 
exploitation, licensing, cross-licensing, protection, hamper competition and reputation.184 
3.5.1 Patents and competitive technical strategy 
The primary application of patents is to protect inventions in a way that allows its 
commercial exploitation, thereby justifying the prior investment. But, as pointed out before, 
patent rights are developing from being a mere protection for company’s innovation to 
                                                   
 
183 Physical assets—property, plant, machinery and stock—represent no more than 40% of the value of world’s 
publicly traded companies. This represents intangibles for value of $19.5 trillion of global market value (from a 
total market value of $31.6 trillion, in 2007). According to Brand Finance, an intangible assets consultancy, cited in 
EPO, Scenarios for the Future, 34. 
184 See also Annex K for a complete list of business motivations. 
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becoming valuable property, a tool even capable of generating revenue per se—by licensing. 
Therefore, patents are more and more being considered as strategic business tools, with the 
overall purpose of increasing revenue. 
Businesses interested in patents’ beneficial value are probably increasing their R&D budgets, 
but to transform the results of the research into a patent portfolio they also require a solid 
patenting strategy.185 Patent generation at any cost is probably not the only consideration 
when conducting innovative research in a given field—as innovation is intrinsically 
unscheduled. Nevertheless, having a clear understanding of the patent process and 
incorporating it into the R&D work method is, at least, a guarantee for a better cost-
effectiveness.  
Cost and value of a patent will be considered in this analysis, following the classical 
economic theory of value. The balance between cost and value would be specific to each 
applicant business, and most often than not, also specific to the patent they want to issue. 
The certainty of costs should be therefore balanced with the hypothetical benefits. Once a 
company has achieved a patentable invention, it should develop a plan of proceeding, given 
their financial position and risk perception.  
Framework 
To set up a competitive technical strategy will require: a good understanding of the new 
invention’s field, its competitive environment, the future market of the invention and its 
chances within this market. 
What follows is a description of the main elements affecting patent strategy decision-making. 
a. Size and type of business 
Strategic patenting has a wide range of objectives depending on the different economic 
actors present in the patent game, being financial disposability and appetite for risk among 
the most salient traits of such strategy. The study will be centered in some archetypical 
economic players: individuals, SMEs, large companies and public research institutions. 
                                                   
 
185 Junghans, Levy, Intellectual Property Management, 35. 
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i. Individual inventors 
Due to current innovative processes and costs of proper research in highly technical fields, 
inventions coming from individual inventors are not as numerous as they have been 
historically. For an independent inventor, filing a patent means high (or totally impractical) 
costs, and normally has to secure financing by external means.  
Inventors notably follow all the process of protecting their inventions for a future monetary 
compensation.186 Provided there is an economic incentive behind patent application, 
inventors pursue the creation of a business start-up for the commercialization of new 
products. In addition to the inherent costs of a patent application, the set up of a business 
will certainly become a financial obstacle, just as cumbersome as the patent process. In that 
case, independent inventors could consider licensing their products, form a joint-venture, or 
make an outright sale of the patent. Each one of them has a clear focus on generating 
economic value, with different levels of risk. 
Independent applicants should, therefore, pay attention to the framework they are about to 
enter with the products or processes to which protection is sought; substantively, the market 
and existing competition in the field. Litigation with a competitor—whether is a plaintiff or 
defendant—is, as a general rule, impractical for individuals.187 
As has been previously emphasized, individual applicants should be concerned with their 
financial position through the process of patenting. Inventors willing to apply for a patent 
would only do so by obtaining public or corporate sponsorship, which could require 
compulsory licensing. Or, more drastically, they could sell the invention to a company, 
bypassing the patenting process. 
                                                   
 
186 One way or another, patents are used to provide a direct or indirect economic benefit. In Why Do Start-Ups 
Patent there are presented the basic reasons or primary driver to patenting. Every one of these drivers had an 
economic interest, with the exception of the latter: “some inventors just want a patent so they can frame it and put 
it on the wall;” in Graham, Stuart, Sichelman, Ted, Why Do Start-Ups Patent? (2008), 2–6.  
187 Even though, US case law has seen litigation cases in which an individual inventor successfully sues a 
company for patent infringement. I.e., the case of Mr. Kearns and the lawsuits against GM, Chrysler and Ford, 
concerning a patented windshield wiper. See Seabrock, John, “The Flash of Genius,” The New Yorker, January 11, 
1993. 
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On the other hand, patent protection could give the necessary funding élan for an 
independent applicant to generate a start-up. In this regard, it is worth observing that 
business investors are generally more interested in the person than in the idea.188 
Occasionally, individual inventors can also be the workers of a company. Their status with 
respect to the ensuing patent has been discussed in section 2.5.3, and is defined by the 
territory, the invention’s field, the company, and the contract. In some circumstances, worker 
inventors can keep ownership of rights.  
ii. SMEs 
Small companies are faced with different challenges by reason of their size.189 In the 
Darwinian market of today, patent protection is often vital for this type of enterprise if they 
are seeking to grow independently; failing to grow independently could result in 
cannibalization by larger companies.190 Having a market share secured by patent 
protection—ideally a monopoly—could provide a beneficial position from where to grow. 
A large proportion of the innovation in enterprises is not the result of casual invention, but 
the consequence of opportunistic and systematic R&D activity.191 Investments are therefore 
required, with the involved risks. If at first this circumstance could seem hampering for 
SMEs patent activity, the fact is that the relationship between the patent system and SMEs is 
particularly fruitful. Indeed, SMEs and start-ups are largely associated with creativity and 
innovation.192 The virtue of the marriage between patent system and innovation is debatable, 
but there is no doubt that the entrepreneurship in highly technological fields must be 
                                                   
 
188 When investing: few individuals possess all the skills to develop an invention; investors reluctant to back one-
person ventures; many businesses will not deal with individuals.EPO Inventors’ Handbook §5.3. 
189 Although the exact number is not important for the study, SME will be referred with the EU designation, that 
is, of 10 to 250 employees. 
190 EPO, The economic importance of patents (Munich: EPO, 2008). 
191 Keupp, Marcus, et al., SME-IP 2nd Report: Economic Focus Study on SMEs and Intellectual Property in Switzerland 
(Bern: Swiss Federal Institute of Intellectual Property, 2009), 10. 
192 Bosma, Niels, Harding, Rebecca. Global entrepreneurship monitor: GEM 2006 results (London: GME, 2007), 16. 
V Í C T O R  M O R A  R O D R Í G U E Z   T E L E C O M  B C N  –  U P C  84 
accompanied by a certain level of innovation. And it is precisely the protection of this 
innovation the main reason explaining patenting behavior of SMEs.193 
In the field of ICT, SMEs are challenged by global markets, and it is usually the case that the 
former lack the necessary assets—both financial and immaterial—to reach consumers 
worldwide. Specialization and collaboration is, then, crucial for SMEs to maintain 
competitiveness, and application of patents on contract negotiations and cross-licensing is 
desirable or highly recommended. Another important use of patents for SMEs is technology 
licensing for economic revenue. Notably for start-ups patents are also considered a way of 
rising finance during the starting phase.194 
But SMEs face also important barriers in the use of the patent system. First and foremost, 
they face direct costs: applying for a patent in the principal economies of Europe or 
worldwide could really hamper global aspirations of a small company.195 Furthermore, the 
difficulty of monitoring whether infringement is committed and the overwhelming costs of 
litigation processes could be devastating for a small enterprise. Protection takes too long to 
materialize for SMEs to achieve full resourcefulness of the patent—being it protecting the 
industry or financing. SMEs are concerned about uncertainty of the patent system, and an 
unfair perception is present in studies and surveys.196 As a result, currently SMEs make very 
little use of the patent system: not only the actual number of applications is very small, but 
also they do not resort to the disclosed material that thirds’ granted patents could provide 
them. 
iii. Large companies 
As pointed out before, patents and other form of IP are an increasing value for large 
companies: patents guarantee rights and positions in the market that, in most jurisdictions, 
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are otherwise prohibited. The focus of a technical big enterprise is therefore the development 
of a strong patent portfolio to achieve the better possible trading position. 
In a traditional development of a patent strategy based on engineers and attorneys the aim 
was basically to decide what inventions to patent and in what countries. Current patent 
strategies, however, require taking into account a wider range of company departments, 
including their different perceptions and responsibilities. It will take no less than the 
combined effort of engineers of R&D departments, product managers, marketing, 
commercialization, executive managers and legal counselors to achieve an overall company 
patent strategy of a company. For example, engineers could focus on a first-to-market basis 
and business development could focus on licensing or using patents to force deals.197 
Large companies, in contrast with all the other agents previously discussed have a totally 
different financing and risk perception. This fact provides these companies with a higher 
variety of possible uses of their patent portfolio: from licensing and cross-licensing to 
internal use for product protection; or even more ‘dubious’ actions: i.e., use patents to block 
competitors and set a litigation base. Given the previous list of patents’ beneficial uses, large 
companies usually deploy researchers and attorneys to evaluate opportunities for 
exploitation of their patents in the technology landscape. Their surveys will likely cover 
other key companies participating in the market in order to determine whether they are 
future competitors, partners or potential acquisitions.  
Indeed, historically, bigger companies have been considered stronger in patenting; in fact, 
propensity to use patents and other IPRs increases with business size.198 This business 
propensity and reliance on their patent portfolios is changing the scope of these enterprises. 
Strategic deploy of patents and other IPRs could provide a company with a beneficial market 
position: it may become a dangerous core technology owner or a licensing-centered business. 
In the ICT market, collaboration—or understanding, at the very least—between companies is 
crucial in the development of highly complex products.199 Failing to do so may result in 
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threats and actual patent lawsuits with unpredictable and often negative outcomes. Bigger 
companies could also use the threat of litigation to force deals with smaller companies with 
interesting key patents.200 
iv. Universities and public research institutions 
Historically, universities and research institutions have been one of the most relevant sources 
of knowledge and ideas, being companies the traditional developers for the potential market 
effects of those ideas. During the last two decades, changes on the legal framework,201 the 
increasing value attached to knowledge, and the global openness of all economic agents have 
changed the philosophy of the research institutions and universities towards obtaining the 
maximum benefit of their research. In the era of the entrepreneurial university,202 research 
priorities are being oriented towards social needs and profitable applications, with a special 
attention to the commercial value of the knowledge it generates—therefore, with a patent 
portfolio strategy.  
It is not surprising, then, to hear critical voices against the new economic and patent activity 
of universities and public research institutions from different angles.203 For starters, it has 
been pointed out that public research institutions, being funded by public capital, should not 
protect their research and thus prevent public access to their results. Also, some claim that 
the entrepreneurship of the research institutions may delay publication of the work, and 
restrict the free diffusion of scientific knowledge. I would argue that the academic research 
results are not significantly hampered by the new patent paradigm of universities. Provided 
that researchers do not present their results prior to applying for a patent, publication of 
results in scientific reviews is possible only some time after the completion of the research. It 
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is not incompatible with filing a patent, and in fact the patent application is published 18 
months after filing.204 
It has been pointed out that, as agents patenting their research and not having a priori 
interaction with the market to commercialize that research, universities should be considered 
‘trolls.’205 But, something can also be said to counteract such a view. In the first place, 
patenting has not affected the quality of university research,206 which contrasts with the 
arguably lesser quality and more opportunistic patenting of PLECs—also known as ‘trolls.’ 
In addition, whereas licensing is the easiest and more common option for universities to 
obtain economic benefits from their work, there is also a good number of new productive 
businesses based on academic R&D—spin-offs.  
Thus, the main uses of patent portfolio for universities and public research institutions are, 
primarily, to license their work to corporations and, to a lesser degree, to form spin-offs or 
businesses based on patented research. These activities provide these institutions with 
revenue, which in turn can fund new research. This virtuous circle of university self-funding, 
however beneficial, places the new competitiveness and economic scope of contemporary 
academic research once more on the spotlight. While it may be beneficial and desirable to 
push commercial competitiveness into universities and research centers,207 it may be 
detrimental to the quality and public interest. 
b. Nature of the product 
Patent strategy is not only concerned with business characterization; convenience of 
patenting depends as well on how the products invented are going to be sold. Selling a 
product requires a strategy on its own. Besides the future marketability of the idea—which is 
probably one of the most important strategies—, companies and investors are also be 
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interested in the manufacturing costs, the need of further development of the idea to make it 
saleable, and in devising ways to fit the products in their long-term business plans. 
Nonetheless, exceptions aside,208 marketability of a product is as much a precondition for its 
manufacture as it is for its patentability. 
But patents introduce some restraints of their own. For example, marketable inventions 
require a patenting strategy different from typical business behavior. Essentially, first-mover 
advantage is hampered by the particular timings of patent applications. In today’s high-tech 
production, in which a short time-to-market is crucial, and products are rapidly replaced or 
improved, patents risk being obsolete after the patenting process—which typically takes 3-4 
years. On the other hand, obtaining a patent for critical components of an undisclosed core 
mobile technology could prove very attractive, given the spread of its use. 
As shown before, in certain fields, quick obsolescence and high competitiveness marks the 
pace of patent strategy. The same is true of renewal, as business will probably liberate their 
old patents if they yield no market benefits against yearly maintenance costs. In others fields, 
such as pharmacological industry, companies prefer, on the contrary, to delay the patenting 
process as much as possible in order to extend the 20-year protection given by the patent. 
Developing a patent strategy requires market reports and commercialization planning—both 
essential elements for a patented invention as well as for an already-known product. At this 
point, it is important to emphasize that, after all, a patent is not exactly a monopoly—at least 
not from a business point of view. Inter-patent dependence, patent enforceability and cost 
issues are always casting their shadow on the day-to-day business activity.209 
The convenience of patenting in more than one country could emerge in different ways. 
When a realistic commercialization plan has been developed, and international markets are 
within the company’s objectives, it is advisable to protect the business’ interests by 
patenting. Not having the necessary resources to market abroad, however, is not as crucial as 
procuring partnerships to produce and/or commercialize your products in other countries 
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209 Junghans, Levy, Intellectual Property Management, 6. 
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by way of licensing. A strong patent protection is then required and, formally, also another 
IP, as trademarks and designs. 
c. Competition 
Achieving patent protection for a product does not guarantee its success. The protected 
invention must be translated into revenue and market share. Markets are defined by 
technical needs and psychological desires, not by products or inventions. Active competition 
of rival companies and substitutive products and processes to the patented one must also be 
taken into consideration. 
Features of competing products or processes will often be similar to a patented invention. 
Ideally, excluding this competition is what an applicant seeks by patenting. As already 
pointed out in section 2.3.1, it is not possible to set the scope of protection to already known 
competing products, but, at the time of filing, a patent applicant must think about possible 
technical roundabouts for the patented invention that competing companies could 
implement.  
Preempting the competition may be done by means of broader claims—deforming the scope 
of the patent to protect possible roundabouts—, or by directly protecting the substitutive 
products. It is worth remembering that broader claim benefits should be weighed against 
costs (direct costs of application and more-than-probably increased litigation costs). On the 
other hand, some national patent legislation (it is the case of Spain,210 for instance) requires 
the applicant to actually use or produce the object of protection in a given time and, as such, 
preemptive protection of competitive developments has added difficulties. 
It is important to remark that any action based on a patent strategy towards the gaining of 
market place or blocking a competition advantage is to be studied in terms of costs versus 
benefits. Most likely, the competition of a company will present a non pre-empted product to 
compete with the protected one. The question is whether all the effort invested in defensive 
patenting could be better achieved by other means, such as marketing or branding.211 
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As previously noted, the size of the applicant was one of the most characterizing elements of 
the framework of a patent strategy patenting. Not surprisingly, the size and type of 
competing businesses is likely to determine the level of threat the patent applicant could 
expect to face in the future. 
Variables  
Formulation of coherent objectives of a patent strategy will require paying attention to the 
already defined framework. In addition to that, business eager to enter the patenting process 
could employ a series of variables to subtly adapt the process to its needs. Possible filing 
pathways and breadth of application claims are the adapting variables here. 
In order to fit their needs, applicants can determine mostly at their convenience the timing 
and number of patents’ applications, the countries selected and the sequential order to where 
the patent will be applied.212 Short life cycle products, and products and processes benefiting 
from a quick market response, will likely need to keep the patenting process as short as 
possible. Conversely, patents for inventions with a steady value over the life of the patent 
right would benefit from delayed decision-making and late right concession. Delaying and 
extending the protection over time is crucial for pharmaceutical companies, whose highly 
lucrative products typically require more than 10 years to be prepared for the market.213 
The possible alternatives filing strategies offer different approximations to the timely needs 
of the applicant. Basically, the PCT is used as a strategic waiting room that could extend the 
patenting process up to 5 years, giving plenty of time to the applicant to prospect the market 
for example. Applying in multiple national offices, on the contrary, is the quickest way to 
achieve the granting of a patent—and doubtless the most expensive.214 In fact, for inventions 
that benefit from a short time-to-market lag, a combined solution may prove better. National 
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patent applications for fast moving markets and a delayed application (under the PCT) for 
other economies will benefit from the two alternatives.215 
The second variable is claim breadth, and a patent applicant can use it at will. The scope of 
the protection, that is, the technological area covered by the claims is one of the factors that 
influence the usefulness of the patent right, basically by hampering the competition and 
raising its economic value. 
It is in the best interest of the applicant to file as broad a claim as possible. The advantages 
are clear: it confers optimal protection against forthcoming technology, excluding the 
competition from the market and raising the value of the patent in the events of licensing or 
selling it. However, patents with excessive claim breadth could increase the likelihood of 
encountering opposition from the competition. Besides, broader claims could prove 
challenging when it comes to pass an inventive step examination in patent offices. These 
issues could raise uncertainty and potential litigation, with the risk of delayed procedures 
and higher costs.216 In any event, the technical area covered in the claims should be 
sufficient, ideally, to cover the needs of protection for the applicant’s business.217 
Costs 
When balancing the decision of maintaining one or another specific patent strategy, 
businesses should compare the potential benefits, still unclear, with the costs involved, 
which are usually more straightforward. 
By the time a business considers to integrate a portfolio of patents from their innovation, 
there are costs that most certainly will be faced, both direct to the patent process and 
indirect. The direct costs will be the patent attorney and office fees, in the first place. And, of 
course, if the invention is deemed to be marketed, one should be aware of the indirect costs 
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related to this effect, such as management time, prototyping, marketing and business 
development.218 
This cost model should be based mainly in the applicant’s approach to risk and budget; 
therefore, it will be different depending on the capabilities of the different types of agent 
discussed in this section. Specially complicated is the situation of an individual inventor or 
start-up, who not only has to balance benefits with costs, but be concerned with the cash 
position through the process. Maintaining a positive reserve of capital during patent drafting 
and application, possible negotiation of licenses and, why not, prosecution of patent 
infringers is particularly difficult for these small agents. That is the case of unsupported 
inventors, who typically abandon applications relatively early in the process,219 mostly as a 
consequence of an unrealistic commercial expectation and lack of capital.220 
But there are also other types of costs that should be of concern to every type of player. As it 
has been discussed in section 2.4.2, patent litigation is an extremely expensive activity, both 
in terms of time and money, either when defending the validity of a patent in court or suing 
an infringer. It is by comparing the certainty of these costs with the plausibility and scale of 
revenue that a business should value their strategy towards achieving an ideal patent 
portfolio.  
3.5.2 Patent portfolio valuation 
As has been already remarked earlier, immaterial assets, such as patents, are of strategic 
importance in the overall value of businesses. However, some questions arise while 
analyzing this fact: how can a company calculate the value of a patent? Is there an 
internationally accepted method to do so? Before these questions are addressed, it is worthy 
to note how the need for patent valuation has gradually increased to become such an 
important and urgent issue. Patents need to be valued for their use in a broad set of 
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transactions: first, when determining where to apply for a patent and whether to renew an 
active patent right; over time, businesses have been interested in calculate value of patents 
while negotiating over licensing fees and analyzing patent portfolios of competitors; in 
recent years, the exploitation of patents as financial assets to secure investing and bank loans 
has finally deemed valuation essential for businesses. This evolution is illustrated in the 
annex M. 
In practice, there are many methods for valuing patents and, more generally, all IP. It is 
difficult to provide a quantitative evaluation of a patent right, not just because of the options 
present, but also because the value may vary significantly depending on, for instance, who 
owns the technology.221 The principal evaluating methods of IP are: cost, income and market 
approach,222 presented in Annex N. 
All three methods have their advantages and disadvantages, and the most suitable one must 
be chosen on a case-by-case basis.  
Typical indicators of the value of a patent are the number of forward citations, that is, 
references to the patent made in latter documents that indicate its scientific importance.223 
Other indicators of patent value are: the patent family relationship; lifespan of the patent; 
whether oppositions were filed and its outcome; and the number and quality of the claims.224 
All in all, the internal use of patent valuation is only half of the story. International 
agreements such as Basel II and IFRS225 require businesses to account for their IP. 
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Valuation of their patent portfolios is not only an interesting matter for businesses when they 
have to account for their intangible assets, it is also a required issue according to 
international adequacy agreements. But, for starters, this accounting is not even governed by 
standards, and by far patent systems’ uncertainty—as it is always possible to challenge 
granted patents—will require to re-evaluate patent portfolios constantly to keep in track 
with technology pace of change. In my opinion, there has not been sufficient rationalization 
of such matter, and there is too much subjectivity in IP accounting valuation to be considered 
unbiased. Admittedly, the EPO specifically has a system of patent and IP valuation—
IPscore—,226 but its use is not worldwide spread, in any case. 
And it is not a small issue. In 1999, some authors227 noted that a massive potential upside for 
businesses started with the valuation and licensing of their IP, and accounted for an 
interesting amount of immaterial asset wealth unaccounted and unexploited.  
Undervaluation of patent portfolios implies a lower potential income for business, but the 
dangers of overvaluation of patents and IP are still unknown. 
3.5.3 Business use for patent information 
The different benefits of patents for protecting inventions, secure a market share and provide 
an economic value for a business have already been discussed. It remains to be seen what are 
the benefits a company or inventor could obtain by using others’ patents. Indeed, patents are 
a source of information about innovation in different fields, which is one of the 
characteristics of the patent system. 
And information in patents can also be incorporated into the strategy of businesses in 
different angles: recent technological developments, competitors’ activity and market 
prospection are useful resources that can be obtained.228 
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Traditionally, patent information has always been related to technology searches, with an 
interest in finding out already-existing solutions to solve a technical problem. Today, it could 
also serve as an indicator of future developments in technology. Interested in gaining some 
advantage in the technological race, agents could use patent information to recognize signals 
at an early stage, which will enable optimization of their research activities. At the same 
time, developing an overview of the market from patent information is essential to locate 
trends and assign R&D budgets accordingly. In the same way, it is important to check that 
there is no infringement of a thirds’ patent scope of protection when developing or 
marketing a new product or service. 
Patent information is useful to determine the capabilities of companies. It is possible to 
obtain information about competitors’ activities often long before the corresponding 
products reach the market, to determine if they are addressed to new technical areas and 
what is their international coverage. And it is also possible to find potential licensing or 
cooperation partners in the same manner. 
There are many reasons for companies to use the available patent information to help 
decision-making in the events of researching new products. Whereas large companies are 
aware of the benefits of searching patent literature, it has been reported229 that SMEs are 
underusing this virtually-free information source.  
Henceforth 
Patents can encourage innovation and economic growth under certain conditions and 
hamper it under others. The impact of patents on innovation and markets is very complex, 
and a fine-tuned patent system is crucial in the overall economy. 
In the ICT market, traditional barriers to entry are becoming transient: capital is cheap; labor 
is mobile; first-mover advantage is rapidly outdated; brand is ephemeral. Companies are 
realizing that among the few remaining barriers to entry the market are patents.230 
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4  T E C H N O L O G Y  D R I V E R S  &  T H E  P A T E N T  S Y S T E M  
The pace of technological advance is increasing at an accelerating rate. As complexity 
increases and the newest technologies converge and integrate with each other, so it does the 
potential number of innovative processes. Can the patent system adapt to this ever-changing 
nature? 
4 . 1  T H E  C O L L A B O R A T I V E  A P P R O A C H  
The romantic image of the inventor experimenting in his or her basement, and eventually 
developing a new technology,231 does not reflect the process of modern implementing of 
inventions. Today, processes of innovation have replaced the ‘flash of genius’ from 
nineteenth-century inventors, for a highly cumulative,232 sequential233 and complementary234 
process.  
Together with this cumulative process, the fact that the different types of technology 
converge permits an increased complexity of the final products, with a larger number of 
interconnected innovative components. These complex products are less likely to be 
developed in a sole organization, but from the effort of technology networks, in which 
corporations are largely related by their patents and other IP. However, is the protection 
conferred by patent systems as useful in this type of interconnected setting as it was in 
typical stand-alone innovation? Due to increased patenting, the ownership of knowledge in 
technical fields is increasingly fragmented, therefore impeding practical diffusion and access, 
and thus threatening the ideal concept of ‘standing in the shoulders of giants.’235 
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232 Murray, Fiona, O’Mahony, Siobhan, Reconceptualizing the Institutional Foundations of Cumulative Innovation, 
(Princeton: University of Princeton, 2005), 3. 
233 Bessen, James, Maskin, Eric, Sequential Innovation, Patents and Imitation (Cambridge: MIT, 1999), 20. 
234 In the sense that different research lines are selected by the different innovative agents, ibid. 
235 EPO, Scenarios for the Future, 29. 
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And yet, key factors for future technological development such as integration, 
interoperability236 and standardization could be hampered by this ‘patent mosaic.’237 
Integration and interoperability are critical for the developing of ICT products, either if they 
work as peripherals, or share the same interfaces, protocols and languages. The boundaries 
between the technologies of these products are becoming blurred, and it is therefore crucial 
to address the issue of fragmenting ownership of technology.238 
Technical development increases, as the diffusion of new technology also accelerates.239 This 
acceleration not only makes new technical products available anywhere in the world at 
virtually the same time, it also shortens the overall market life of these products, as new 
gadgets are being constantly developed. 
It is precisely at this moment of technology fast obsolescence and clogged patent system that 
national patent offices are confronting a challenge that may change the way they work, 
presented in Figure 2. Multidisciplinary technologies and an overall increased rate of 
patenting are leading to difficulties when it comes to examine these highly complex 
applications that require both a high level of knowledge and quite some amount of time. 
 
 
                                                   
 
236 Principal interoperability in the ICT industry is provided in Annex H. 
237 ‘Patent mosaic’ designates the fact that a high number of patent holders own part of a technology niche. The 
term has been taken from a report by Schacht, Wendy H, Patent Reform: Issues in the Biomedical and Software 
Industries, Congressional Research Service report for US Congress, RL33367 (2006), 11. 
238 Frain, Tim, Patents in Standards & Interoperatibility (2006), 3. 
239 I.e., it took 50 years for the telephone to be adopted by ¼ of the US population. Mobile phones achieved the 
same result in only 7 years. EPO, Scenarios for the future, 26. 
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Figure 2 – Issues in technical scenarios 
Source: EPO, Scenarios for the Future 
 
4 . 2  P A T E N T  T H I C K E T S  
The results of convergence of technology and cumulative innovation processes can be seen in 
highly complex products from the ICT field such as smart-phones or tablets. Each one of 
them can contain hundreds (or thousands) of patented developments in the overall sum of 
their components and the tools required for their fabrication.  
The commercialization of such a complex product requires that every patent holder grant 
permission to the use of his or her protected component or process.240 In order to prevent 
any possible infraction lawsuit, a producer may need hundreds of licenses to bring one 
                                                   
 
240 If a patent holder chooses to do so, he or she can simply deny any other party the right to use their idea. 
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product to the market241 at a high risk: if one of the patent right holders refuses to license 
their technology, it may impede the product to reach the market.242 
The scenario where a great number of patents converge around a single technology product 
is called a ‘patent thicket,’ and is one of the most important challenges in the sectors of 
semiconductors, computing science and telecommunications.243 Fragmentation of IPRs 
among a plurality of agents in such cumulative innovation systems prevent further 
innovation based on former contributions; and can also hamper the diffusion of novel 
technologies to society.244 
Rarely a sole company will hold all the patents involved in the production of a single high-
tech product. So, the combination of multiple patents around a single innovative product 
could lead to ‘hold-up’ situations, and royalty stacking.245 This situation encourages 
companies to further apply for patents in search of a stronger portfolio, and using this 
portfolio as a negotiation tool or, in extreme cases, as a counter-threating weapon. Patents 
are no longer to win exclusive rights over a new technology, but for their value as strategic 
tools—defensively, to ward off infringement suits, or offensively as a means of blocking 
competitors’ products. 
This increasing propensity to patent creates even more dense thickets, in a vicious circle that 
is aggravated by the inherent problems of the already-backlogged patent systems. The 
growing number of applications does not necessarily imply a rise in innovation; in fact, 
                                                   
 
241 I.e., production of a smart-phone could suppose the payment of royalties for 200–300 patents, about 15–20% of 
the final selling price. The Economist, “The great patent battle.” 
242 This situation could be proven worse if the product already being mass produced, or already being 
commercialized, is the objective of an injunction—a legal halt of the production or commercialization. 
243 Which are in fact the sectors that concern this study. 
244 The phenomenon of patent thickets is also referred to as the ‘Tragedy of the anti-commons’ in the literature. As 
an opposite to the ‘Tragedy of the commons,’ describing the problem of the overuse of free valuable resources by 
all individuals involved. The opposite—the ‘Tragedy of the Anti-Commons’—, concerns about the problem of too 
many people owning parts of a valuable resource. A possible outcome, then, is the blocking of the resource by 
intern veto. Loosely based in Heller, J., The Gridlock Economy: How Too Much Ownership Wrecks Markets, Stops 
Innovation, and Costs Lives (New York: Basic Books, 2008); cited in Surowiecki, James, “The Permission Problem,” 
The New Yorker, August 11, 2008. 
245 ‘License stacking’ or ‘royalty stacking’ is the adverse situation caused by the existence of a high number of 
patents relating to a particular technology, which requires the payment of license fees to many patent owners. 
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backlogs could result in an increased probability of patent grants, which could, in turn, lead 
to lesser-quality patents246 and, as a result, to a growing number of patent thickets. In any 
case, it seems difficult that a situation of zero-sum game could imply a rise on innovation. 
In technologies in which dense patent thickets define the landscape of manufacture and 
development, different strategies can be developed by the concerned organizations willing to 
skirt the thicket, or simply gain an economic advantage. Enterprises interested in the 
utilization of other parties’ IPRs could make use of cross-licensing247 and patent pools, which 
is a similar concept but not so much spread. 
4 . 3  P A T E N T  P O O L S  
In order to skirt the possibility of patent infringement lawsuits in situations of high density 
and division of ownership of patent rights, manufacturers could arrange a patent pool. 
Namely, a patent pool is an agreement between different patent holders to pool a package 
with all patents related to a given technology, and to offer licensing of this package for a 
fixed fee, to those owners and any third parties. These agreements are reached to overcome 
the problems resulting of patent thickets, while still maintaining innovation incentives 
related to IPRs. Pools also help reduce license transaction costs, distribute risks between the 
members and provide better exchange of information, as some authors have pointed it out.248 
Recent technologies and standards249 are examples of these arrangements.  
Although pools are useful in these technological patent-dense areas, the idea of a pool is not 
new. It was introduced in the US airplane industry in the late 1910s,250 followed by others in 
                                                   
 
246 An undesired effect already discussed in section 3.3. 
247 Cross-licensing is an agreement between two parties, consisting on the mutual granting of licenses. The 
concept is discussed in section 2.5.4. 
248 Clark, Jeanne, Patent Pools: a Solution to the Problem of Access in Biotechnology Patents? (USPTO, 2000), 6. 
249 Examples of recent patent pools are the DVD and the W-CDMA standard for 3G. 
250 The Manufacturer’s Aircraft Association was crucial to the U.S. government because the two major patent 
holders, the Wright Company and the Curtiss Company, had effectively blocked the building of any new 
airplanes, which were desperately needed as the United States was entering World War I. Jeanne Clark, Patent 
Pools, 4. 
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the radio and television frequency standardization.251 The concept has vastly proliferated in 
the last 20 years, when the industry has found it handy for the development of technical 
standards or protocols for new technologies. 
The management of patent pools is a complicated task. What was before an act of solely 
private agreement between the organizations involved with one of them administrating the 
pool, nowadays the model is slightly different with businesses specialized in pools’ 
administration. In fact, three different models coexist today: 
Conjoint license. The patent right holders designate an intern administrator for the licensing 
of the IPR package; this is the traditional method, i.e., Philips in DVD3.  
External administration. Corporations specialized in patent pools administration take the 
initiative of pool formation. They are also the agents for licensing, charging royalties and 
arranging the distribution of revenues. Examples of this type are MPEG LA and 
ViaLicensing. 
Patent platform. They appeared in order to solve specific problems of highly complex 
technologies. Here, an independent organization values the different IPRs, preceding a latter 
bilateral negotiation between parties. The main purpose of this type of system is to 
standardize the process of forming a pool, and increase ‘transparency’ and ‘cleanness,’ with 
regard to the principal antitrust regulation bodies. One of the current examples is the 3G 
Patent Platform Partnership, or 3G3P. 
That being said, the principal use of patent pools in the ITC field is the setting of standards. 
Technical standards appear for the sake of homogeneity and interoperability and are meant 
to result in a public good. However, because of the standard nature of wide sharing, they are 
susceptible of being affected by patent blocking. Standard setting has problems similar to 
those affecting patent thickets, but is somewhat more strongly affected by ‘hold-up’ 
situations—as it is more difficult to ‘invent around’ once the standard is set.252 
                                                   
 
251 Further information on the history of patent pools at Ibid. 
252 Examples of patent disrupting standard setting are SDRAM (Synchronous Dynamic Access Memory), which 
was amended by Rambus, one of the former members of the organization, and UMTS standard, which infringed 
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The convenience of patent pools has been widely discussed. Patent pools strike directly at 
the problem governing patent thickets, as some authors have pointed out.253 Resuming the 
concept of the ‘Tragedy of the Anti-Commons,’254 the more technological innovations’ 
property is divided into small IPRs, the more difficult it will be to manufacture new products 
based on that technology. Along these lines, some claim that the limitation of intellectual 
property rights seems necessary to the effectiveness of these same rights.255 Likewise, 
underuse of innovative resources created by excessive ownership does not have visible 
effects—mainly, inventions which will not get made.256 
On the contrary, some claim that patent pools do not correct all the existing problems in 
situations of royalty stacking, as the ‘outsider problem’257 still affects pools—the members 
can abandon it when they consider there is a better business for their IPR.258 Not only that, 
but cooperation between horizontal competitors is viewed with suspicion by antitrust 
authorities.259 Private agreements like patent pools may reduce the possibility of being sued 
by members, but could increase litigation for hampering free competency, antitrust or 
antimonopoly practice. 
                                                                                                                                                               
 
Qualcomm patents. There are numerous standards with ‘better luck,’ as GSM and UMTS; JPEG, GIF and MPEG; 
DVD and HTTP. 
253 Bessen, James, Patent Thickets: Strategic Patenting of Complex Technologies (Research on Innovation, 2002), 19. 
254 See note 244. 
255 Heller, The Gridlock Economy; cited in Surowiecki, The Permission Problem. 
256 Surowiecki, The Permission Problem. 
257 Bessen, Patent Thickets: Strategic Patenting of Complex Technologies, 20. 
258 “When something you own is necessary to the success of a venture, even if its contribution is small, you will 
tend to ask for an amount close to the full value of the venture,” reads one of the conclusions of the study by 
Vanneste, S., Depoorter, B., Putting Humpty Dumpty Back Together: Pricing in Anticommons Property Arrangements 
(Washington: George Mason University School of Law, 2004), 25. 
259 The Economist, “Patently Absurd?” 
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4 . 4  P A T E N T  ‘ T R O L L S ’ 260 
Business dependence in IP, and patents in particular, has been increasing in the last thirty 
years.261 The fact that the value of this immaterial property is intensifying has ease the way 
for the appearance of new players in the exploitation of patent rights. This new type of 
businesses relies basically on licensing or selling ownership of their patents, which are 
obtained by their work on R&D.262 
But the most controversial of this new type of businesses are Patent Licensing and 
Enforcement Companies—PLECs, derogatorily called ‘trolls.’263 PLECs are based on patent 
rights as leverage for license and infringement claims, without producing themselves. These 
patent rights are either filings of patent application for inventions—in the hope they may 
have a base for litigation with a third-party that would use the invention later on—264 or are 
acquisitions of patents to be used with the same objective as before.265 Patent ‘trolling’ is 
essentially done in markets where the cost of litigation is too high, and companies therefore 
prefer to settle.266 
But it is in complex technical fields where patent ‘trolls’ obtain more lucrative results: 
integration and interoperability make patent blocking an easy task. Whole industries and a 
large number of companies could be infringing a core element of technology. Likewise, 
because of technological complexity, companies could increase their chances of inadvertent 
                                                   
 
260 A patent ‘troll’ takes its name from the mythological creature depicted as an ugly monster, which lives under a 
bridge and asks for a toll when hikers cross. 
261 As seen in section 3.5. 
262 I.e., universities and individual inventors, but also less-known ‘technology development companies,’ such as 
Intellectual Ventures. More information on the latter type could be obtained in Gladwell, Malcolm, “In the air: Who 
says big ideas are rare?” The New Yorker, May 12, 2008. 
263 The term is widely used in the field. 
264 The case concerning BlackBerry email system, confronting RIM v NTC (which was finally settled off-court) is 
an example of this case. Surowiecki, James, “BlackBerry Picking,” The New Yorker, December 26, 2005. 
265 “The term “troll” is more likely to be applied to someone who generates ‘paper-invention’ patents or buys up 
patents, and then, with little regard for their valid scope, asserts that those directly active in the marketplace 
should pay royalties for continuing to do what they are already doing, or else stop their operations.” ICC, Current 
and emerging intellectual property issues for business, 23. 
266 For this same reason, the patentee-favorable US courts (after the formation of CAFTA in 1982), made ‘trolling’ 
a commoner issue in the States. 
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infringement. ‘Trolls’ are deemed more damaging for ICT companies because normal 
proceedings on patent blocking are not useful anymore: enterprises cannot use their patent 
portfolio in cross-licensing arrangements or counter-infringement claims to force 
settlements—‘trolls’ are not interested in manufacture.267 
The question of ‘trolls’ is thus important to the ICT field and its relation with the patent 
system, and some measures must be taken. First, the system needs to be rigorous in the way 
patent are granted—avoiding too obvious, too broad, or well-established ideas.268 In the 
same sense as described in section 3.3, questionable patents are a significant concern and can 
harm innovation. Also, in order to reduce the power patent ‘trolls’ have to halt production 
and manufacture in infringement cases, a weakening of the injunction figure—in cases where 
the patent owner has no intention to manufacture—has also been proposed.269 
But it is necessary to point out that these countermeasures are not exempt of problems: these 
changes could be damaging to innovation processes, as universities and private inventors 
without means to commercialize are technically ‘trolls,’ after all. 
In spite of their shortcomings, patent ‘trolls’ have become part of the patent system, yielding 
quite a lucrative business in the technological market. 
4 . 5  ‘ R E S E A R C H  E X E M P T I O N ’  A N D  R E S E A R C H  T O O L S  
As often remarked previously, patent owners are granted the right to prevent third parties 
from using, making or selling their invention for a limited time. However, most European 
national patent laws apply certain exceptions of infringement to this right: essentially, to 
                                                   
 
267 Reitzig, Markus, et al., On Shark, Trolls, and Their Patent Prey: ‘Being Infringed’ as a Normatively Induced Innovation 
Exploitation Strategy (2006), 27. 
268 Likely, ‘trolling’ is not as usual in Europe as it is in the US: in the latter, 99% of patent applications are 
approved. In Surowiecki, BlackBerry Picking. 
269 Injunction weakening for public interest was actually proposed in the case eBay Inc v. MercExchange, L.L.C., 547 
U.S. 388 (2006), on the ‘direct-buy’ and ‘buy it now’ features. Also discussed in Reitzig, On Shark, Trolls, and Their 
Patent Prey, 23. 
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private acts without commercial scope and experimental purposes on the matter patented.270 
The latter of the two exceptions—freedom to experiment on the patented matter—is 
commonly referred to as ‘research exemption,’ thus providing with a framework of further 
innovative development using patent disclosure.  
Indeed, it is important to find a balance between legal certainty of patent rights and the 
promotion of research in the matter protected. A strong research base is crucial to the 
competitiveness of national economies, and to achieve a full application of the social 
principle of increasing innovation behind the patent system. As such, the exception only 
extends to experiments addressed to generating genuinely new information,271 and should 
have a direct connection with the subject matter of the invention. 
Given a close interpretation of the law, only the experimentation on a patent product is 
susceptible to be exempted of infringement of a patent right. Experimentation with a patent 
product is not exempted. According to the law, patented research tools are therefore not 
comprised in the ‘research exemption,’ and would entail a patent infringement whenever 
applied, even in experimental labor.272 
Having presented the legal precepts governing the issue of experimenting with patented 
tools, it seems essential to point out that these precepts governing research tools affect 
investigation in the fields concerned negatively. Specifically in bioengineering and genetics, 
where a patent over a DNA sequence as a research tool is particularly adverse273 since in this 
                                                   
 
270 See section 2.4.2. Also, it is generally exempted the use of patented matter on foreign ships and aircrafts 
crossing national waters or airspace as well as manufacture of pharmaceutical products, in preparation for a 
patented product becoming generic—also called ‘Bolar’ provision.  
271 The ‘research exemption’ does not extend, then, to experiments designed to simply verify existing knowledge. 
272 According to the British case of Smith, Kline and French v Evans Medical (1989, FSR 513)—Not exemption: “A 
contrary conclusion would, in practice, deprive the words ‘relating to the subject-matter of the invention’ of any 
meaning as [the article referring to the ‘research exemption’] would apply in all cases where experiments were 
carried out which involve the use of an invention.” 
273 This is the case of BRCA1 and BRCA2—two breast cancer genes patented by Myriad Genetics in 1998—, which 
provided debate on this issue, due to excessive restrictive licensing. They are currently in the hotspot: in 2009 
these two patents were challenged by the American Civil Liberties Union (ACLU). At CNN, “ACLU sues over 
patents on breast cancer genes,” May 12, 2009,  
http://edition.cnn.com/2009/HEALTH/05/12/us.genes.lawsuit/index.html (accessed April 26, 2011). 
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field it is almost impossible to ‘invent around.’ Although certain scientific authorities have 
questioned patents on research tools in certain areas,274 no consensus has yet been achieved. 
To sum up, it is safe to say that the patentability of research tools is a sensible matter 
affecting to the capacity to foster further innovation within the scientific community by 
reducing the available tools, at least the public ones. A more conclusive assessment of this 
issue seems particularly elusive. 
4 . 6  S I N G U L A R  C A S E S  O F  P R O T E C T I O N  
From traditional inventions on mechanical products or processes, patents have been granted 
to protect chemical products, biotechnological inventions, software and nanotechnology. 
This broadening of the scope of patent protection is basically due to economic interests in 
pursuing of protection of new matters of protection.275 
This increased number of patentable matter is responsible for the appearance of new 
patenting issues, expressly related to the new subjects such as ‘living material,’ software 
patents, etc. Solutions to these problems have been addressed in essentially two ways: by a 
broadening of the interpretation to accommodate the new patentable matter,276 or by the 
creation of new types of rights.277 
4.6.1 Biotechnology 
Being one of the fastest growing fields of technology of the last decades,278 biotechnology has 
today an extraordinary impact on health, agriculture and the environment. Biotechnology 
                                                   
 
274 In this case, the British Royal Society: Keeping science open: the effects of intellectual property policy on the conduct of 
science, (London: The Royal Society, 2003); and the Summary Report of the CSIC/OECD/OEPM Conference on the 
Research use of Patented Inventions (Madrid: May 18–19th 2006), 12, where it was reported that “Firms seldom 
abandon a research project after having discovered the existence of a patent on a research tool.” 
275 Hilty, Reto, “Pressures on a unitary system,” Policy options for the European patent system (Brussels, 2006), 38. 
276 I.e., software protection in the USPTO and JPO. 
277 As the International Convention for the Protection of New Varieties of Plants (Paris, 1961). 
278 Yet, precedential cases of biotechnological patents go back as far as the mid-nineteenth century. In 1843, a 
method for producing yeast cultures was patented. And in 1873, chemist Louis Pasteur patented another yeast-
making method. 
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covers a wide range of areas, from medical applications to agriculture, genes and 
microorganisms. Considering the critical importance of this technology and the powerful 
market it provides, debate has generated about the convenience of biotechnologies 
patenting, both in the industry and the general public. 
But the public is more concerned about the potential risks and ethical implications of 
biotechnological applications, in particular GMOs, human embryonic stem cells or cloning, 
than in purely patentability issues. In any event, critical opinions on patents in the 
biotechnology field are not only concerned with ethical implications per se,279 they also point 
at the inconvenience of an exclusivity right over innovations in such essential areas. In the 
same sense, some authors and even researchers280 point out that gene production should not 
be considered an invention, but a discovery, instead, and therefore not subject to 
patentability. On the other hand, economic studies281 have repeatedly shown that some 
important innovation would have never reached the market without patents.  
This ongoing debate is related with the everlasting conflict of the principles driving the 
patent system (as it has been stressed enough during the study), that is, the compromise 
between the need to protect the public good, while reckoning the rights of patent owners 
and the contribution of patents to foster innovation. In the case of biotechnology, however, 
the matter affected by this regulation are critical elements related to social wellness such as 
food and health, what should doubtless provide a different parallax on the problem.282 
In Europe, patentability of biotechnical inventions is judged by applying the basic 
requirements,283 but in the particular of biotechnology-related inventions secondary 
legislation applies, mainly because of the debate on the matter just mentioned. So, the 
                                                   
 
279 And indeed essential ethical implications exist in some cases, i.e., the ‘Edinburgh patent’ of 1999, covering 
animal embryonic stem cells—as ‘animal’ could be interpreted as including humans—; and the ‘Oncomouse,’ 
patented in 1988, a mouse genetically designed to suffer cancer to aid studies of the disease. 
280 According to Martin Khor, the Nobel-Prize winner John Sutton presented the case in a WIPO seminar while 
drawing the map of the human genome: “These are naturally occurring genes, you can‘t patent them because 
they are naturally occurring. I discovered it, but I did not invent it.” EPO, Interviews for the Future, 492. 
281 Ibid. 
282 At least, political, economic and scientific decision-making is affected. 
283 Which were presented in section 2.3. 
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European law permits the patentability of inventions related to biotechnology, with the 
exceptions of methods of diagnostic, treatment, surgery or therapy of humans and animals, 
plant and animal varieties, and biological processes for plant or animal production.284 In the 
US, applicants may patent genes and parts of genes, though genetic sequences (ESTs) are not 
patentable.285 
Also, it should be remembered that because of the especially sensible matter involved, some 
inventions in the field of biotechnology are susceptible to be considered contrary to the 
‘public order’ or morality.286 Human cloning and exploitation of human embryos are two 
examples. In any case, these issues are open to debate, and ethical implications of these 
technologies could be further discussed. 
4.6.2 Software 
Computers are present in almost every area of modern life, from the most complex technical 
tasks to simple human interaction. Due to their extended use, an increasing number of new 
inventions related with computers are filed at the national patent offices. While the US and 
Japan patent offices grant patents for software; in Europe applicants need to prove that their 
inventions implemented in a computer constitutes a technical improvement. In the EPO 
nomenclature, software and other computer-related inventions are referred to as Computer-
Implemented Inventions or CIIs.287 
Therefore, in Europe, software programs are not patentable ‘as such.’288 During the 90s, 
software programs were indeed considered mental acts performed by programmers, and 
therefore were not considered as inventions.289 Exclusion was afterwards revised at the end 
                                                   
 
284 Arts. 52 and 53.b EPC 
285 According to the USPTO Gene Patent Guidelines. 
286 Art. 53a EPC 
287 As defined by the EPO, a CII is an “invention that works by using a computer, a computer network or other 
programmable apparatus.” 
288 The phrasing changes in the different national laws, but the fact remains the same: i.e., in the UK and Spain, 
software ‘as such,’ or per se is not eligible. 
289 See, for example, decisions of the EPO’s Boards of Appeal, cases T 833/91, T 204/93 and T 769/92 (OJ 1995, 
525). 
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of the decade290 and, today, CIIs are not excluded as long as the programs applying for a 
patent cause a further technical effect—that is, beyond the inherent interaction between 
program (software) and computer (hardware). In that sense, technical control operations 
implemented by a computer method are also patentable at the EPO.291 
It must be said that CIIs and software are not a priori excluded in all their forms; nonetheless 
they are still referred to as non-patentable in the EPC art 52(2). Whether patents should be 
granted to software inventions in all cases, never, or only in the special circumstances 
considered by the EPO is an ongoing debate.292 
In the US, on the contrary, software patents have been granted for thirty years; ever since the 
(in)famous “everything made under the sun by man is patentable” was coined in 1980.293 
The Australian patent office also provides protection to software-related inventions that 
conform to a ‘useful economic or commercial result.’294 Japan also grants patents for 
software, with a doctrine closer to the EPO—patents for a ‘very advance creation.’  
To understand the current patent policy on software in the USPTO, one should understand 
that protection of software programs has always been a pressing matter for the bigger ICT 
development companies in the United States.295 Overseas, programs’ protection in European 
countries has usually been granted using copyright,296 following the Berne Convention of 
                                                   
 
290 In the decision T 1173/97 (OJ 1999, 609), largely based on article 27.1 TRIPS. 
291 In T 6/83 (OJ 1990, 5), the board found that an invention “relating to the co-ordination and control of the 
internal communication between programs and data files held at different processors in a data processing system 
having a plurality of interconnected data processors in a telecommunications network, the features of which were 
not concerned with the nature of the data and the way in which a particular application program operated on 
them, was to be regarded as solving a problem which was essentially technical.” Case Law of the Boards of Appeal of 
the EPO, 24. 
292 With regard to the jurisprudence of France (Schlumberger case, 1981), Germany (Seitenpuffer case, 1991), and 
EPO cases (Viacom, 1996; IBM 1997), which were contrary to an exclusion of computer programs from 
patentability. 
293 Case Diamond v Chakrabarty, 1980, 447 US 303. 
294 IP Australia Patent Guidelines. 
295 Bain, Malcolm, et al., Propietat Industrial, (Barcelona: UOC, 2008), 44. 
296 Along with other reasons already discussed, copyright is for a company not as interesting as patents because 
ownership is granted to the author who is normally an employee. Licensing is also easier through patents. It 
could prove useful to review issues about inventions’ ownership. See section 2.5. 
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1971. In that way, certain limits to the copy of code were set, but limits to reverse engineering 
where still quite blurred (it is still possible to imitate the ideas with different instructions of 
code). The algorithm—which is both the most creative and important part of the software 
program—is therefore not sufficiently protected for the requirements of the software 
industry. The interest of the big ICT companies on software patenting is precisely the 
protection of the algorithm or the idea behind the code. In that way, third parties could be 
stopped from producing a program using different instructions yet based on the same idea, 
thus solving the problem of copyright-protected programs. In any case, patents provide 
stronger rights, more difficult to confront and therefore more valuable. On the other hand, 
patents are quite expensive processes, in terms of time and money, and the products and 
processes protected may not have a lifespan long enough for the patent to be considered 
useful. 
Debate on the field of software patenting is partly centered on the fact that the publication of 
the source code is not compulsory, nor is the publication of patents’ application or grant.297 
In my opinion, this reserve of know-how, which is kept secret by the applicant, diminishes 
the legal certainty of third parties, although, I am aware that there is no legal basis to request 
it.298 
But patentability of computer programs is not only a problem of legal uncertainty and cross-
licensing game for agents in the ICT industry; it is also a challenge for patent offices. 
Examination processes are even more complicated, as the search of previous ‘state of the art’ 
related to a particular software application could prove a boundless purpose, due to the lack 
of fully disclosure and the fast pace of changes. Despite the rapid growth of patents for CIIs 
in Europe and the US, the proportion of this type of patents on the overall number of patents 
is still small. Businesses rely mainly on first-timer advantage, secrecy and copyright to 
protect their software products and investments, not on patents.299 
                                                   
 
297 EPO, Patents for Software? European Law and Practice, (Munich: EPO, 2009), 12. 
298 Ibid. 
299 Ghosh, Rishab Aiyer, “Software patents, economic evidence and competition,” Open Forum on the Substantive 
Patent Law Treaty (Geneva: WIPO, 2006).  
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The principal opposition against patents for computer programs comes from the Open 
Source movement, which provides ground to a complementary market for established 
software monopolies and licenses, based on free distribution of products using a special 
form of copyright contract. OS is, in fact, an alternative system to patenting software, as 
shown in Annex O. 
4.6.3 Business methods 
Business methods are plans, rules or processes for carrying out activities of economic, 
financial or commercial character. In Europe, they are not eligible for patentability per se,300 
only when, as a process, the business method provides a solution to a technical problem—
which is a basic requirement for the granting of any patent according to the EPC.  
In the US, on the contrary, methods for doing business were deemed patentable following 
the State Street Bank decision in 1998; which aroused a boom of patenting of not only 
business methods, but also internet-based business methods. This latter type secured a high 
number of allegedly ‘obvious’ patents,301 as Amazon’s one-click.302 
4.6.4 Integrated circuits 
Under this label it is made reference to the circuits made from semiconductor materials, 
which are the core elements of electronic industry. These integrated circuits are realizations 
of a particular circuit that solves a technical problem, but are not patentable by themselves. 
The inherent characteristics of integrated circuits—they are only getting smaller and 
complex—303 makes designing them costly; in fact, the investing required raises inversely 
proportional related to their size. But, on the other hand, copying and producing an 
integrated circuit is a relatively easy task—raw material and manufacturing are pretty cheap.  
                                                   
 
300 Methods for doing business are not considered inventions by the articles 52.2.c EPC, see also section 2.3.4. 
301 Other examples of ‘lucky winners’ are: USPTO patent no. 5,862,223 “Selling professional advice over the 
internet,” and no. 5,797,127 “Reverse auctions, where the buyer sets the price,” both by Jay Walker et al., from 
Walker Asset Management. Appearing in The Economist, “Patent Wars.” 
302 In Europe, Amazon’s one-click was also filed, granted and amended, before being finally rejected. 
303 Almost 50 years ago, Gordon Moore coined his law for development in chip technology: he predicted doubling 
of the capacity and halving of the cost every 12–18 months. 
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Hence, protection was needed for topographies, this special type of ‘designs.’ This protection 
was introduced in the mid-80s in the principal IP offices.304 The protection of a 
semiconductor topography includes the schematics of the circuit configuration or tri-
dimensional disposition, where the elements and components of the circuit are integrated in 
a semiconductor substrate—the chip or semiconductor plaque. The reproduction and 
commercial exploitation of the protected topography are granted to the right holders for ten 
years, beginning at the end of the year when the topography is first registered or exploited. 
The products protected in this way are usually marked with a T inside a circle. 
It should be noted that, similarly to other inventions, layout designs of semiconductors are 
notably developed by employees of corporations. The related issues pointing at authorship 
and ownership of semiconductor topographies are analogous to inventions, already 
discussed in section 2.5.3. 
4.6.5 Nanotechnology 
Being one of the expected key technologies of this century, this growing field of technology 
is relevant to almost any area of engineering and science. And it is exactly the 
interdisciplinarity and complexity of nanotechnology that creates a new challenge to the 
patent system. 
According to the EPO definition, “the term nanotechnology covers entities with a controlled 
geometrical size of at least one functional component below 100 nm in one or more 
dimensions susceptible of making physical, chemical or biological effects available which are 
intrinsic to that size.” In a nutshell, nanotechnology provides a technical effect305 in a 
nanometrical scale.  
But this definition involves a new dilemma: whether a known effect or apparatus being 
downscaled complies with the requirements of patentability, specifically, novelty and 
                                                   
 
304 In particular, the US Semiconductor Chip Protection Act of 1984; Japanese Act on the Circuit Layout of a 
Semiconductor Integrated Circuits of 1985; and European Directive on the Legal Protection of Semiconductor 
Products of 1986. 
305 Biotechnology; information processing, storage and transmission; materials and surface science; interacting, 
sensing and actuating; optics and magnetics, etc. 
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inventiveness. In general, a smaller version of a device is not novel in itself; patent 
applications need to meet additional criteria to be considered patentable. And the same is 
true for inventiveness: does miniaturization involve an inventive step? Following the EPO 
application guidance306 in this case, if the solution provided by the invention is the 
enhancing of a technical effect in a selected sub-range, the device could be considered new. 
In order to be inventive, the technical advantage provided by the invention should not be 
found in the prior technical art, and it should not be an obvious effect for a skilled person to 
arrive at. 
Finally, these criteria should be complemented by a greater need of ‘sufficient disclosure’ at 
the patent application of a nano-device: the highly sophisticated methods for manipulation 
at those scales could go well beyond the knowledge of a skilled person in the field—or even 
beyond the knowledge of an expert. Sufficient information on the performing of the 
invention should be provided, specifically detailed information about the processes and tools 
used.307 
4 . 7  ‘ O N E - S I Z E - F I T S - A L L ’  
Besides the relatively little legal differentiation presented in the previous examples of 
singular cases of patents—which is mostly concerned with the suitability of a particular 
matter to be patentable or not—there is hardly any differentiation in the degree of protection 
granted between different kinds of technology.  
This generalization of protection by patent systems—the ‘one-size-fits-all’ approach—may 
not be satisfactory at all. As pointed out before, patent systems are facing difficult challenges 
in particular complex technology fields; as an example, ICT-related industries are negatively 
affected by patent thickets and blocked standardization. Many voices in the industry claim 
for “shorter” and “faster to obtain” exclusive rights for complex technology patents and 
                                                   
 
306 EPO, Nanotechnology and patents (Munich: EPO, 2009), 10–13. 
307 However, it is also true that by means of disclosure of methods and tools used, particular know-how of the 
research company could be exposed in such a way. 
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business methods;308 whereas pharmacological industries are quite happy with the 
protection granted by patents. Indeed, a twenty-year-patent protection seems ludicrous in 
ICT areas, with an expected lifespan of the products of less than 3 years.309 
One of the principles behind patent systems justification is to provide an appropriate market 
framework for justifying the disclosure of an invention, and obtaining an economic benefit. 
But not every field of technology obtains the same benefits from the system: while 1–2 
patents cover a typical pharmacological product; a complex technical product could be 
protected by 100–1000 patents.310 The first instance comes close to an ideal monopoly for a 
pharmacological product; the second to hardly an incentive at all.  
And there are even further differences. The possibility of potential blockage is higher in 
complex technical fields, where a product is covered by a large number of patents; in discrete 
innovative industries, it is negligible.311 Innovation in the fields of biotechnology and 
pharmacology is relatively more expensive312 when compared to ICT and software 
technologies. Consequently, not all kind of innovations obtains the same economic benefits 
from a granted patent, and whether they deserve an identical degree of protection requires 
separate consideration.  
The ‘one-size-fits-all’ approach is notably sustained in the contents of the TRIPS agreement, 
particularly in article 27.1, which determines that the conditions of protection are the same 
for any type of technology,313 and article 33, which defines the minimum temporal patent 
protection—20 years. However, the text of the agreement leaves some freedom to apply 
limitations to patent rights in certain areas, taken into account the legitimate interests of third 
                                                   
 
308 For example, Amazon’s CEO Jeff Bezos and Tim O’Reilly, editor of manuals on open-source software. The 
Economist, “Patent Wars.” 
309 Michael Blakeney. At EPO, Interviews for the Future, 31. 
310 Shinjiro Ono. At EPO, Interviews for the Future, 252. 
311 Complexity of a product defines the number of patents covering the final product, being discrete a product 
covered by a little number of patents, and complex one product being affected by a large number. 
312 Typical costs of developing a pharmacological product and bringing it to the market could be on the order of 
€100million. Shinjiro Ono, at EPO, Interviews for the Future, 252. 
313 Where it is stipulated that, apart from the exceptions included in arts. 27.2–3, “patents shall be available and 
patent rights enjoyable without discrimination as to . . . the field of technology . . . .” (art. 27.1 TRIPS). 
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parties.314 In fact, as some authors have already pointed out, these limitations do not need to 
be identical in all fields of technology, since the economic and socio-political impacts of the 
different fields may vary.315 From which follows that patent systems may be susceptible of 
amends in different technologies in a non-conflicting fashion with the TRIPS agreement. 
Over- and under-protection are the two undesired consequences of the current approach of 
‘one-size-fits-all.’ Possible solutions to these problems relate to a ‘split’ in patent granting 
between protective oriented patents,316 for mainly discrete innovation; and defensive 
patents,317 more closely related to cumulative innovation. In this sense, some experts have 
been arguing on the convenience of maintaining a strong patent protection in areas such as 
the pharmaceutical industry, but establishing a compulsory license framework—license of 
rights regime—318 in the case of ICTs, whose final objective would be creating an injunction-
free industry-wide virtual partnership.319 Whereas it is still debatable if this measures could 
prove determining in diminishing the problems related to ‘hold-up’ situations in these fields, 
it is undeniable that patent rights are weakening, and that change is inevitable. 
Henceforth 
Absolute ownership right over a patented invention grants a patent holder to deny any other 
party the right to use his/her idea—for as long as the patent is valid. In particular fields of 
technology—where a high number of patents covering a complex product—that simple fact 
is deemed to be the cause of issues with patent thickets and the blocking of technical 
standards, providing leverage to PLECs and reducing access to research tools. The ‘one-size-
fits-all’ approach is weakening patent protection in the ICT field. 
                                                   
 
314 Art.30 TRIPS, which is also the legal base for compulsory licensing of generic pharmaceutical products in 
public health crisis, together with art. 31.b. 
315 Hilty, Pressures on a unitary system, 39. 
316 Protection-oriented patents are more interested in securing the return of the investment, i.e., pharmacological 
and biotechnological. 
317 Corporations made use of defensive patenting to basically gain freedom to operate, with typical sectors of this 
approach being ICT and software. 
318 Frain, Patents in Standards & Interoperatibility, 4. 
319 Reichman, Jerome H., “Of Green Tulips and Legal Kudzu: Repackaging Rights in Subpatentable Innovation,” 
Vanderbilt Law Review 53 (2000), 1777. 
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5  C O N C L U S I O N S  A N D  F U R T H E R  W O R K  
5 . 1  C O N C L U S I O N S  
• From the point of view of innovative agents, the principal problem of the patent system 
is the uncertainty in the rights conferred by patents, due to lack of harmonization among 
national patent offices and the overall diminishing quality of patents granted. This 
uncertainty is responsible for unbalanced situations and higher costs on litigation. Some 
of the suggested solutions are: convergence of processes in the principal patent offices, 
stricter examining processes and introduction of opposition systems before and after 
granting. The objective is to grant the applicants fair protection for their inventions, 
while guaranteeing the legal certainty of third parties whose activities are affected by the 
patent. 
• The model of the patent system works on the assumption that the production of one 
innovative product corresponds to just one patent. In the ICT industry, because of its 
distinctive features, ownership over patents covering a product is shared (forming 
overlaps or ‘patent thickets’). Patent overlapping increases the probability of blocking 
parties and lowers revenues—the incentives to innovate. Patent pools, standardization, 
cross-licensing and compulsory licensing are measures proposed by certain ICT 
industries, but are related to other problems, mainly anticompetitive practice. 
• ‘One-size-fits-all’ (applying the same patent approach to all technologies) is no longer 
feasible for maintaining an equal level of innovation incentive in the different technical 
fields. In the ICT market, patents confer lesser incentives in certain high-complex 
technologies compared to other fields, and also diminish lead-time advantage due to the 
pendency of the granting patent process. All in all, patent system may have disrupting 
effects on complex technology-related markets, so further regulation and/or patent 
system alternatives may be needed. 
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5 . 2  F U R T H E R  W O R K  
These are some proposals of further study on the issue that may be implemented: 
• To completely characterize the ICT-field relationship with the patent system, it is 
necessary to further analyze the special case of software. The relation of software 
with patents (in the US and Japan) and copyright (Europe) require an approach 
inherently different to hardware. Likewise, the relation with proprietary software 
and Open Source software is lacking—practically—in a physical context. 
• From investigation and analysis to application. It is necessary to study the legal 
amends and regulative measures that may be done in ICT-related law—not 
conflicting with the international and European legal framework—to achieve the 
objectives proposed. 
 
 A P P E N D I X  
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A .  I S S U E S  A F F E C T I N G  T H E  P A T E N T  S Y S T E M  
 
 
Figure 3 – Challenges for the patent system 
Source: EPO, Scenarios for the Future 
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B .  D E T A I L  O F  A  E U R O P E A N  P A T E N T  
 
 
 
Figure 4 – Detail of a European patent file 
Source: Dachs, et al., Europe’s strengths and weaknesses in IST 
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C .  G R A N T I N G  P R O C E S S E S  A T  E P O & U S P T O  
 
 
* May be appealed 
 
Figure 5 – Patent granting processes in the EPO&USPTO 
Source: EPO, USPTO & JPO, Trilateral Statistical Report2005 
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D .  T H E  P C T  P R O C E S S  
 
 
 
 
 
Figure 6 – Patent granting process under the PCT 
Source: WIPO, Seminar Presentation of the PCT 
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E .  C O N T R A C T I N G  S T A T E S  
European Patent Convention (EPC) contracting states (May 2011) 
Albania 
Austria 
Belgium 
Bulgaria 
Cyprus 
Croatia 
Czech Republic 
Denmark 
Estonia 
Finland 
The former Yugoslav 
Republic of 
Macedonia 
France 
Germany 
Greece 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Liechtenstein 
Lithuania 
Luxembourg 
Malta 
Monaco 
Netherlands 
Norway 
Poland 
Portugal 
Romania 
San Marino 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
Turkey 
United Kingdom 
Bosnia and 
Herzegovina* 
Montenegro* 
Serbia* 
*extended states 
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Patent Cooperation Treaty (PCT) contracting states (May 2011) 
United Arab 
Emirates  
Antigua and Barbuda  
Albania 
Armenia 
Angola 
Austria 
Australia  
Azerbaijan 
Bosnia and 
Herzegovina 
Barbados  
Belgium  
Burkina Faso  
Bulgaria  
Bahrain  
Benin  
Brazil  
Botswana  
Belarus  
Belize  
Canada  
Central African 
Republic 
Congo  
Switzerland  
Côte d’Ivoire  
Chile  
Cameroon  
China  
Colombia  
Costa Rica  
Cuba  
Cyprus  
Czech Republic  
Germany  
Denmark  
Dominica  
Dominican Republic  
Algeria  
Ecuador  
Estonia  
Egypt  
Spain  
Finland  
France  
Gabon  
United Kingdom  
Grenada  
Georgia  
Ghana  
Gambia  
Guinea  
Equatorial Guinea  
Greece  
Guatemala  
Guinea-Bissau  
Honduras  
Croatia 
Hungary  
Indonesia  
Ireland  
Israel  
India  
Iceland  
Italy  
Japan  
Kenya  
Kyrgyzstan  
Comoros  
Saint Kitts and Nevis  
Democratic People’s 
Republic of Korea  
Republic of Korea  
Kazakhstan  
Lao People’s 
Democratic 
Republic  
Saint Lucia  
Liechtenstein  
Sri Lanka  
Liberia  
Lesotho  
Lithuania  
Luxembourg  
Latvia  
Libyan Arab 
Jamahiriya  
Morocco  
Monaco  
Republic of Moldova  
Montenegro 
Madagascar  
The former Yugoslav 
Republic of 
Macedonia  
Mali  
Mongolia  
Mauritania  
Malta  
Malawi  
Mexico  
Malaysia  
Mozambique  
Namibia  
Niger  
Nigeria  
Nicaragua  
Netherlands  
Norway  
New Zealand  
Oman  
Peru  
Papua New Guinea  
Philippines  
Poland  
Portugal  
Romania  
Serbia  
Russian Federation  
Seychelles  
Sudan  
Sweden  
Singapore  
Slovenia  
Slovakia  
Sierra Leone  
San Marino 
Senegal 
Sao Tome and 
Principe  
El Salvador  
Syrian Arab Republic  
Swaziland  
Chad  
Togo  
Thailand  
Tajikistan  
Turkmenistan  
Tunisia  
Turkey  
Trinidad and Tobago  
United Republic of 
Tanzania  
Ukraine  
Uganda  
United States of 
America  
Uzbekistan  
Saint Vincent and the 
Grenadines  
Viet Nam  
South Africa  
Zambia 
Zimbabwe 
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F .  C O S T  O F  A  S A M P L E  E U R O P E A N  P A T E N T  
 
 
* 18 pages, 6 states, 10-year term. Excl. in-house preparation costs for the patent applicant. All values rounded 
 
 
Figure 7 – Cost of a sample European patent 
Source: EPO, USPTO & JPO, Trilateral Statistical Report2005 
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G .  T E C H N O L O G I E S  A N D  N E E D  O F  V A R I E T Y  
 
 
PHARMA BIOTECHNOLOGY 
COMPUTER 
HARDWARE AND 
SEMICONDUCTORS 
SOFTWARE 
Innovation type mainly discrete 
discrete and 
cumulative 
cumulative cumulative 
Number of 
patents per 
product 
(complexity) 
few 
medium, high for 
research tools 
high high 
Importance of 
interoperability 
negligible negligible high high 
Blockage 
potential of 
patents 
negligible 
negligible, except 
for research tools 
high high 
Innovation costs very high very high medium low 
Product cycle long short-long short short 
Patent use 
protective (return 
of investment) 
protective (return 
on investment) + 
attract capital 
defensive 
(freedom to 
operate) 
defensive 
(freedom to 
operate) 
Major 
alternatives IP 
approaches 
none none trade secrets 
copyright and 
open source 
 
Table 1 – How technology is demanding variety from patenting 
Source: EPO, Scenarios for the Future 
 
T H E  P A T E N T  S Y S T E M  I N  T H E  G L O B A L  I C T  M A R K E T :  A  C R I T I C A L  A N A L Y S I S  129 
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Figure 8 – Essential interoperability in the ICT field 
Source: EICTA, Interoperability White Paper 
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I .  C L A S S I F I C A T I O N  O F  I C T S  
1. Electronic elements and devices320 
a. Passive elements 
b. Semiconductors  
c. Screens and display devices  
d. Electro-acoustic elements  
e. Radiofrequency tubes and elements 
f. Antennas  
g. Cables  
h. Interconnection elements  
i. Batteries  
j. Other electronic elements and devices  
 
2. Manufacturing processes outsourced  
a. Plaques and subsets  
b. Equipment  
c. Other manufacturing processes outsourced  
 
3. Consumer electronics equipment  
a. Digital and analog support 
b. Wireless terminals and devices  
c. PCs and components  
d. Peripherals  
e. Access equipment to communications networks  
f. Audio Equipment  
g. Video equipment  
h. TV-receiving equipment  
i. Digital Photography  
j. Game consoles and electronic-entertainment equipment  
                                                   
 
320 From AETIC, Análisis y propuestas de delimitación del sector de la electrónica y las tecnologías de la información y las 
telecomunicaciones (Madrid: Ministerio de Industria, Turismo y Comercio, 2005), 15–17 (my translation). 
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k. Equipment location and orientation  
l. Other consumer electronic equipment  
 
4. Professional electronics 
a. Instrumentation and measurement  
b. Electronics for defense, detection and navigation  
c. Electronics for physical security  
d. Electro-medicine and bioengineering  
e. Industrial electronics  
f. Automotive electronics  
g. Equipment and systems for audiovisual production and transmission 
h. Power systems  
 
5. Telecommunications equipment 
a. Access networks equipment and systems 
b. Transport networks equipment and systems 
c. Core network equipment and systems  
d. Terminals and switchboards  
e. Software platforms for applications and services  
f. Basic services and engineering 
 
6. Information technology systems industries 
a. Manufacture of information technology equipment  
b. Office equipment  
c. Software  
d. Computer Services  
e. Telematics services  
f. Consumables  
 
7. Audiovisual and telecommunications services provision  
a. Fixed communications  
b. Mobile Communications  
c. Internet access  
d. Audiovisual  
e. Satellite  
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f. Phone information and user guides  
 
8. Services associated with information technology and communications sector 
a. Consulting and advice  
b. Certification  
c. Training  
d. Customer service 
e. Other services related to ICTs  
 
9. Content Production  
a. Phonographic  
b. Film and television production  
c. Video game production  
d. Editorial content Production  
e. Content Editing and packaging  
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Table 2 – Total patent applications by field of technology(2003–2007) 
Source: WIPO, World Intellectual Property Indicators 2010 
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K .  B U S I N E S S  M O T I V A T I O N S  F O R  P A T E N T I N G  
Businesses seek patent protection for a variety of reasons. Here is a list of typical reasons:321 
• Commercial exploitation  
o Building monopoly position 
• Preventing lawsuits 
• Licensing  
o Generating license income 
o Building a base for infringements claims 
• Cross-licensing  
o Getting a seat in the table when standards are being set 
• Prevention from imitation  
o Provisional protection of an innovation by having pending applications 
• Blocking competition  
o Blocking others from entering a market 
• Reputation  
o Creating marketing messages and becoming more visible in the market 
• Communicating innovativeness to investors  
• Performance 
o Measuring the performance of the company or individuals 
• Financing 
o Assembling a portfolio of rights to create financial strength 
                                                   
 
321 Built from Graham, Sichelman, Why Do Start-Ups Patent?, 2–6; and EPO, Scenarios for the future, 35. 
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Figure 9 – IP rights and other alternatives measures of protection 
Source: Friesike, et al., SME-IP 3rd Report 
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Figure 10 – Evolution of IP exploitation and valuation demand 
Source: OECD, Valuation and Exploitation of Intellectual Property 
 
T H E  P A T E N T  S Y S T E M  I N  T H E  G L O B A L  I C T  M A R K E T :  A  C R I T I C A L  A N A L Y S I S  137 
N .  I P  E X P L O I T A T I O N  A N D  V A L U A T I O N  –  M E T H O D S  
 
 BASIS CONCEPT METHOD SUITABLE FOR WEAKNESS 
Cost 
approach 
“The investment 
costs for the 
technology” 
Reproduction/re
placement costs 
Reimbursement 
of costs 
New (emerging 
or innovative) 
technologies 
Not correlated 
with future value 
of the asset 
Income 
approach 
“A reliable 
business plan” 
Expected income 
of the 
investment 
Discounted cash-
flow (net present 
value) 
Technologies 
ready for 
commercial 
exploitation 
Subjective 
valuation of 
future cash flow 
relies on 
accurate analysis 
Market 
approach 
“Equal assets 
shall have equal 
price” 
Comparison with 
similar/competin
g technologies 
Market price; 
comparison with 
known cases 
Mature 
technologies 
Suitable 
comparisons can 
be hard to find 
and the data 
difficult to access 
 
Table 3 – Selection of the some of the different methods for valuing IP 
Source: Fröhling, Practical experiences regarding the evaluation of medium-sized  
patent portfolios 
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O .  A L T E R N A T I V E S  T O  T H E  P A T E N T  S Y S T E M  
 
DEFINITION 
CHARACTERIZED 
BY 
USES 
DIFFUSION 
OF TECH 
ECONOMIC 
PROFIT 
Open Source 
Collective process 
on the production 
of knowledge 
based on free 
distribution 
Relies on copyright 
to enforce license 
conditions set by 
creators 
Basically software + - 
License of 
rights/ 
Compulsory 
licenses 
Replacement of 
the monopoly 
conferred by 
patents (exclusion) 
with right of 
remuneration. 
Base for patent 
pools 
Protects 
technological 
innovation while 
allowing natural 
development of 
technology. No 
hold-up situations.  
Possible on high-
complexity 
markets 
+ - 
Open 
innovation 
(push/pull 
systems) 
Systems for 
incentive of 
innovation and 
R&D, based on 
‘smart 
specialization’ 
Supply/Push 
measures: Industry 
and governments 
support certain 
directions on R&D. 
Demand/Pull 
measures: market 
demands certain 
products.  
Pharma research 
in general, and 
orphan drugs in 
particular 
+ - 
Secrecy 
Know-how and 
information of 
technical type, 
deliberately 
maintained 
confidential 
Can be 
fragmentary 
protected by legal 
means 
Almost in every 
field of industry, to 
different extents 
- - 
Patronage and 
prizes 
Direct incentives 
for innovation 
Pre- (patronage) 
and post-incentives 
(prizes)  
Any field. I.e., new 
technology at 
reasonable prices 
for developing 
countries 
Only for supplementary use 
 
Table 4 – Outline of some of the alternatives to the patent system 
Source: Compilation from various sources 
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